+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Biology, Geography & Health: Chapter 35436

Chapter 35436 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.

Rovang, K.S.; Arouni, A.J.; Mohiuddin, S.M.; Tejani, A.; Hilleman, D.E., 2000:
Oral estrogen replacement therapy reduces the diagnostic accuracy of exercise stress tests in women

Vivian, J.A.; Thomas, B.W.; Majersky, L.S.; Yount, I.L.; Grant, K.A., 2001:
Oral ethanol self-administration and circadian measures of temperature and activity in monkeys

Birkle, D.L.; Roberts, A.J.; Moffitt, H.L.; Brennan, M.; Koob, G.F., 2000:
Oral ethanol self-administration on a progressive ratio schedule

Offner, H.; Matejuk, A.; Zamora, A.; Vandenbark, A.A.; Subramanian, S., 2003:
Oral ethinyl estradiol inhibits recruitment of inflammatory cells into the CNS and treats relapsing EAE

Giltay, E.J.; Gooren, L.J.; Emeis, J.J.; Kooistra, T.; Stehouwer, C.D., 2000:
Oral ethinyl estradiol, but not transdermal 17beta-estradiol, increases plasma C-reactive protein levels in men

Alici, S.; Saip, P.; Eralp, Y.; Aydiner, A.; Topuz, E., 2003:
Oral etoposide in platinum-resistant epithelial ovarian cancer

Millicovsky, G.; Sista, S.; Albert, K., 2001:
Oral exposure in dermal studies Confounding factor in drug safety evaluation

Kim, S.; Johnson, V.J.; Sharma, R.P., 2003:
Oral exposure to inorganic mercury alters T-lymphocyte phenotypes and cytokine gene expression in BALB/c mice

Wise, S.B.; Stock, D.W., 2003:
Oral expression of bmp2 and bmp4 orthologs in dentally divergent fishes

Mattes, R.D., 1999:
Oral fat exposure raises postprandial plasma triacylglycerol concentration

Calvert, J.R.chard; Rowlands,; Hobbs, M.A.thony, 2004:
Oral feeding bottle

Majeed, N.; Blouin,; Agarwal, R.; Greenberg, N.; Pollak, M., 2003:
Oral feeding of silibinin reduces in vivo prostate cancer incidence and circulating IGF-I in the TRAMP transgenic model

Manhart, N.N.; Vierlinger, K.V.; Spittler, A.S.; Boltz Nitulescu, G.B.; Bergmeister, H.B.; Roth, E.R., 2000:
Oral feeding with glutamine prevents the endotoxin-caused B-cell diminution Peyers patches of mice

Esquivel Pedraza, L.; Fernandez Cuevas, L.; Ruiz Badillo, A.; Ortiz Mondragon, R.; Mejia Barrientos, F.; Chavana Barquin, E.; Magis Rodriguez, C., 2000:
Oral findings among prisoners in Mexico A pilot study

Loevenich, H.; Keulertz, C.; Schuett Gerowitt, H.; Bethe, U.; Soehngen, D.; Waldschmidt, D.; Cornely, O.A., 2001:
Oral flora and mucositis grade during myeloablative chemotherapy

Plosker, G.L.; Figgitt, D.P., 2003:
Oral fludarabine

Cazin, B.; Maloum, K.; Divine, M.; Lepretre, S.; Travade, P.; Delmer, A.; Jaubert, J.; Lederlin, P.; Dreyfus, B.; Leporrier, M.; Harousseau, J.L.; Grosbois, B.; Maloisel, F.; Eghbali, H.; Dumontet, C.; Benichou, J., 2001:
Oral fludarabine and cyclophosphamide in previously untreated CLL Preliminary data on 59 pts

Cazin, B.; Binet, J.L.; Divine, M.; Lepretre, S.; Lederlin, P.; Travade, P.; Lemaire, G.; Guibon, O., 2000:
Oral fludarabine and cyclophosphamide in previously untreated chronic lymphocytic leukemia Preliminary data

Cazin, B.F.; Maloum, K.; Creteil, M.D.vine; Lepretre, S.; Travade, P.; Delmer, A.; Jaubert, J.; Lederlin, P.; Dreyfus, B.; Leporrier, M.; Harousseau, J.L.c; Grosbois,, 2003:
Oral fludarabine phosphate and cyclophosphamide in previously untreated CLL Final response and follow-up in 75 patients

Zinzani, P.L.igi; Musuraca, G.; Stefoni, V.; Marchi, E.; Tani, M.; Alinari, L.; Gabriele, A.; Baccarani, M., 2003:
Oral fludarabine/cyclophosphamide combination in pretreated indolent non-Hodgkins lymphomas

Sangha, Jangbir S., 2002:
Oral fluid collection device and collection method

Razvi, F.M.; Kritzinger, E.E.; Taylor, K.; Jones, S.; Ryder, R.E.J., 1999:
Oral fluorescein angiography as an additional tool in diabetic retinopathy screening

Razvi, F.M.; Kritzinger, E.E.; Tsaloumas, M.D.; Ryder, R.E.J., 2000:
Oral fluorescein angiography in diabetic retinopathy screening

Lewis, N.L.; Meropol, N.J., 2000:
Oral fluoropyrimidines in cancer treatment

Van Cutsem, E.; Peeters, M., 2000:
Oral fluoropyrimidines in colorectal cancer

Porschen, R., 2003:
Oral fluoropyrimidines in the treatment of colorectal carcinoma

Reid, G.; Habash, M.; Vachon, D.; Denstedt, J.; Riddell, J.; Sofer, M.; Beheshti, M., 2000:
Oral fluoroquinolone therapy results in drug adsorption onto ureteral stents and prevention of biofilm formation

Stuehlinger, M.C.; Paulweber, B.; Schirnhofer, J.; Pachinger, O.; Stanger, O., 2004:
Oral folic acid does not reduce plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in hyperhomocysteinemic subjects

Armada, E.; Otero, A.; Perez, C.; Esteban, J.; Gayoso, P.; Camba, M.; Vazquez, D., 2002:
Oral folic acid is more efficient than oral and intravenous folinic acid for the treatment of hyperhomocysteinemia in HD patients

Holm, T.; Holven, K.; Aukrust, P.; Christensen, B.; Brosstad, F.; Andreassen, A.K.; Ose, L.; Gullestad, L.; Kjekshus, J.; Nenseter, M.S., 2000:
Oral folic acid treatment improves endothelial function in patients with hyperhomocysteinemia

Goede, J.; Hettche, H.; Momberger, H.; Engel, J.; Lobisch, M., 2003:
Oral forms of administration containing solid flupirtine with controlled release of active substance

Joshi, R.; Gore, A.Y.; Rubinfeld, J.; Shrotriya, R., 2001:
Oral formulation for paclitaxel

Sakr, A.A.el; Habib, W.A.del Azim, 1999:
Oral formulation for treatment of bacteria-induced diseases of the colon

Burman, A.C.; Mukherjee, R.; Khattar, D.; Kumar, M., 2003:
Oral formulation of methylglyoxal and its imino acid conjugates for human use

Feng, F.Y.; Zhang, P.; He,; Li,; Zhou, M.Z.en; Cheng, G.; Chen, Y.; Kikkawa, T.; Yamamoto, M., 2002:
Oral formulations of the selective serotonin3 antagonists ramosetron and granisetron hydrochloride in treating acute chemotherapy-induced emesis, nausea, and anorexia A multicenter, randomized, single-blind, crossover, comparison study

Bosch, A.M.; Prick, L.; Ter Horst, N.M.; Van Gennip, A.H.; Wanders, R.J.A.; Duran, M.; Bakker, H.D.; Wijburg, F.A., 2002:
Oral galactose loading does not affect clinical or biochemical parameters in classical galactosemia

Szer, J.; Durrant, S.T.; Schwarer, A.P.; Bradstock, K.F.; Arthur, C.; Kilvington, R.; Australasian Bmt Cooperative Study Group, 1999:
Oral ganciclovir after allogeneic bone marrow transplants Preliminary results from a randomized study

Mouly, S., J.; Aymard, G.; Urien, S., S.; Diquet, B., S.; Bergmann, J.F.ancois, S.; Caulin, C., S., 1999:
Oral ganciclovir intestinal absorption is maintained in HIV-infected patients with diarrhea and weight loss

Firpi, R.J.; Bhardwaj, G.; Nelson, D.R.; Soldevila, C.; Reed, A.; Davis, G.L., 1999:
Oral ganciclovir monotherapy in the prevention of cytomegalovirus disease in liver transplant recipients

Tarshis, G.; Miskin, B.M.; Jones, T.M.; Champlin, J.; Wingert, K.; Brown, M.J.; Breen, J., 1999:
Oral gatifloxacin , 400 mg QD, vs oral levofloxacin , 500 mg QD, in the treatment of uncomplicated skin and soft tissue infections

Hariprasad, S.M.; Mieler, W.F.; Orengo Nania, S.; Holz, E.R.; Bell, N.P.; Gross, R.L., 2003:
Oral gatifloxacin a novel treatment paradigm for the management of filtering bleb infection

Saikawa, T.; Ooie, T.; Takahashi, N.; Nawata, T.; Arikawa, M.; Yamanaka, K.; Hara, M.; Sakata, T., 2001:
Oral geranylgeranylacetone induces heat shock protein and produces protection against ischaemia/reperfusion injury in rat heart

Kreitman, R.; Malley, A.; Klinger, E., 2002:
Oral glatiramer acetate treatment reduces EAE clinical signs in monkeys

Aharoni, R.; Sela, M.; Arnon, R., 2002:
Oral glatiramer acetate treatment results in the accumulation of specific Th2 cells in the central nervous system of mice

Ketteler, J.; Bauer, K.; Hellwig, M.; Versmold, H., 2002:
Oral glucose before venepuncture in neonates reduced pain expression but did not attenuate the increase in O2-consumption and heart rate

Hoenig, M.; Jordan, E.T.; Ferguson, D.C.; de Vries, F., 2010:
Oral glucose leads to a differential response in glucose, insulin, and GLP-1 in lean versus obese cats

Fujimoto, K.; Hozumi, T.; Watanabe, H.; Tokai, K.; Shimada, K.; Muro, T.; Yoshiyama, M.; Takeuchi, K.; Homma, S.; Yoshikawa, J., 2003:
Oral glucose loading suppresses coronary flow velocity reserve on transthoracic Doppler echocardiography in healthy young adults

Garcia, R.L.; Garcia, C.E.; Vieira, J.G.; Parise, E.R., 2002:
Oral glucose overload test identifying insulin resistance in non-alcoholic fatty liver patients

Frier, H.I.; Greene, H.L.; Kaye, W.A.; Florez, A., 2002:
Oral glucose tolerance and the glycemic index of liquid meal replacements Preliminary results

Cure Cure, C.; Cure Ramirez, P.; Hernandez Cassis, C.; Vergel, C.; Lopez Jaramillo, P., 2003:
Oral glucose tolerance test 1 hour value has a strong association with cardiovascular risk factor in Colombian population

Ekman, B.; Nystrom, F.; Lindstrom, T.; Olsson, A.G.; Toss, G.; Arnqvist, H.J., 2000:
Oral glucose tolerance test is valuable for monitoring diabetogenic effects of GH-substitution

Grande, L.; Camacho, I.; Benitez, S.; Romero Gomez, M., 2002:
Oral glutamine challenge correlates with minimal hepatic encephalopathy and predicts overt episodes

Romero Gomez, M.; Grande, L.; Camacho, I.; Benitez, S.; Suarez, E.; Castro, M., 2001:
Oral glutamine challenge in patients with subclinical hepatic encephalopathy

Panigrahi, P.; Horvath, K.; Gewolb, I.H., 1999:
Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage

Todorova, V.K.; Kaufmann, Y.; Hennings, L.; Klimberg, V.Suzanne., 2010:
Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats

Walsh, N.P.; Blannin, A.K.; Bishop, N.C.; Robson, P.J.; Gleeson, M., 1999:
Oral glutamine supplementation does not attenuate the fall in human neutrophil function following prolonged exercise

Komninou, D.; Richie, J.P.Jr, 2000:
Oral glutathione inhibits colon carcinogenesis in rats

Goff, J.P.; Horst, R.L., 2001:
Oral glycerol as an aid in the treatment of ketosis/fatty liver complex

Pinthus, J.H.; Gavish, Z.; Ramon, J.; Leibovitch, I.; Esshar, Z.; Pines, M., 2000:
Oral halofuginone prevents the growth of human prostate cancer in SCID mice

Bassey, G.O.; Anyanechi, C.E.; Ekabua, K.J.; Ekabua, J.E., 2010:
Oral health among antenatal care attendees in Calabar, Nigeria

Park, S.M.; Frohna, J.G.; D.F.nseca, M.A., 2003:
Oral health care for children A community needs assessment

Mello, A.Lú; Erdmann, A.Lorenzini.; Brondani, M., 2010:
Oral health care in long-term care facilities for elderly people in southern Brazil: a conceptual framework

Ortiz, K.A.; Castillo, J.; Hoff, C.J.; Buchi, K.F.; Byington, C.L., 2003:
Oral health habits of toddlers in a county clinic

Domett, K.M., 1999:
Oral health in Southeast Asia

Navas P.Rita; D.M.rales, T.R.jas; Zambrano, O.; Alvarez, C.J.lia; Santana, Y.; Viera, N., 2002:
Oral health in pre-school children Its relation to parental attitudes and educational level

Milgrom, P.; Reisine, S., 2000:
Oral health in the United States: the post-fluoride generation

Terpenning, M.; Shay, K., 2002:
Oral health is cost-effective to maintain but costly to ignore

Simons, D.; Kidd, E.A.; Beighton, D., 1999:
Oral health of elderly occupants in residential homes

Alberth, Márta.; Kovalecz, G.; Nemes, J.; Máth, János.; Kiss, C.; Márton, Ió.J., 2004:
Oral health of long-term childhood cancer survivors

Geltman, P.L.; Cote, S.E.; Nunn, M.E.; Lituri, K.; Barnett, E.D.; Garcia, R.I., 2003:
Oral health of newly arrived refugees in Massachusetts, 2000-2002

Lewis, C.W.; Riedy, C.A.; Domoto, P.K.; Grossman, D.C., 2001:
Oral health of young Alaska Native children and their mothers A population based study

Churchill, S.; Lissy, K.; Delecki, C.; Williams, B.; Villareale, N., 2004:
Oral health risk differences in children with public and private health insurance

Kyriakopoulos, G.; Katsourakis, M.; Aga Koumpitska, E.; Mavropoulou, E., 2000:
Oral health status of haemodialysis patients

Hiebert, L.M.; Wice, S.M.; Ping, T., 1999:
Oral heparin absorption in rats and humans

Carneiro, M.A.; Souza, L.N.; Azevedo, W.M.; Kalopothakis, E.; Victoria, J.M.N.; Gomez, R.S., 2000:
Oral herpes and bone marrow transplantation

Delgado, W.; Meneses, L.; Gotuzzo, E.; Flores, G., 2002:
Oral histoplasmosis in seropositive and seronegative HIV patients

Maestrejuan, A.; Meldrum, M.; Mccabe, E.R.B., 2002:
Oral history of human genetics project

Kadri, N.; Lemay, A.; Dodin, S.; Turcot, L.; Dechene, F.; Forest, J.C., 2001:
Oral hormone replacement therapy but not flaxseed supplementation improves serum cholesterol profile in hypercholesterolemic menopausal women

Wagner, Eugene C., 2000:
Oral hygiene appliance

Stier, R.E.; Zanone, J., 2001:
Oral hygiene compositions which mask the burn sensation and the astringency of eucalyptol and zinc

Kaminski, Basia, 2001:
Oral hygiene device

Yudelman, Clifford A., 1999:
Oral hygiene device having plaque collection and quantification capabilities

Lesky, J.; Lesky, J.; Lesky, T., 2003:
Oral hygiene formulation and method of use

Kholodova, H.; Shinkevich, T.; Karlovich, I., 2000:
Oral hygiene in diabetes mellitus patients

Anderson, Michael R., 2003:
Oral hygiene powder composition and method

Dimopoulos, M.; Panayiotidis, P.; Grigoraki, V.; Poziopoulos, C.; Xilouri, I.; Kiamouris, C.; Tassidou, A.; Gika, D.; Stefanoudaki, K.; Anagnostopoulos, N.; Anagnostou, D., 2001:
Oral hyperfractionated cyclophosphamide and intermittent thalidomide-dexamethasone for previously treated patients with multiple myeloma

Mannel, M.; Koytchev, R.; Dundarov, S., 2000:
Oral hypericum extract LI 160 is an effective treatment of recurrent herpes genitalis and herpes labialis

Matsushima, M., 2002:
Oral hypoglycemic agent How to interpret the results of UKPDS for Japanese?

Langer, O.; Conway, D.; Berkus, M.; Xenakis, E.M.J., 1999:
Oral hypoglycemic agent is comparable to insulin in GDM management A randomized study

Nalysnyk, L.; Ross, S.D., 2001:
Oral hypoglycemic agents in NIDDM A systematic literature review and MetaMap database

Oba, K., 2001:
Oral hypoglycemic agents in the treatment of elderly diabetics

Ruëff, F.; Eberlein-König, B.; Przybilla, B., 2001:
Oral hyposensitization with celery juice

Mclachlan, S.; Murray, R.; Bell, R.; Bergstrom, B., 2004:
Oral ibandronate an effective, well-tolerated and convenient alternative to intravenous bisphosphonates for patients with breast cancer and bone metastases

Teksam, O.; Yigit, S.; Karagoz, T.; Korkmaz, A.; Yurdakok, M.; Tekinalp, G., 2004:
Oral ibuprofen and intravenous indomethacin for treatment of patent ductus arteriosus in newborn infants retrospective study

Raeder, J.C.; Steine, S.; Vatsgar, T.T., 2001:
Oral ibuprofen versus paracetamol plus codeine for analgesia after ambulatory surgery

Lerzo, G.; Campos, C.; Vicente, H., 1999:
Oral idarrubicina and im methotrexate in patients with previously treated advanced breast cancer

Cameron, D.A.; Afseth, J.; Murray, E.; Bowman, A.; Leonard, R.C.F., 2002:
Oral idarubicin and capecitabine A dose-finding study confirms this as a safe, effective 1st line therapy for older women with breast cancer

Musso, M., 1999:
Oral idarubicin in maintenance therapy of acute myeloid leukaemia

Glasmacher, A.; Gorschlueter, M.; Hahn, C.; Goldschmidt, H.; Mezger, J.; Heyll, A.; Maintz, C.; Clemens, M.R.; Haferlach, T.; Derichs, R.; Ko, Y.; Schmidt Wolf, I.G.H.; Gieseler, F., 1999:
Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma Final analysis of a phase II study

Israeli, E.; Goldin, E.; Hemed, N.; Thalenfeld, B.; Engelhardt, D.; Rabbani, E.; Ilan, Y., 2003:
Oral immune regulation using colitis extracted proteins a new mode of treatment for crohns disease results of a phase i clinical trial

Safadi, R.; Israeli, E.; Pappo, O.; Gotsman, I.; Klein, A.; Alper, R.; Rowe, M.; Thalenfeld, B.; Engelhardt, D.; Rabbani, E.; Ilan, Y., 2000:
Oral immune-regulation towards hepatitis B virus proteins A new mode of treatment for chronic HBV infection Results of a phase I clinical trial

Kang, B.S.; Yahikozawa, H.; Palma, J.P.; Kim, B.S., 1999:
Oral immunity provides most efficient protection against TMEV-induced demyelination

Banerjee, S.; Medina Fatimi, A.; Nichols, R.; Tendler, D.; Michetti, M.; Mach, M.; Simon, J.; Kelly, C.P.; Monath, T.P.; Michetti, P., 2000:
Oral immunization against H pylori in healthy volunteers with low dose E coli enterotoxin and recombinant urease

Lauterslager, T.G.M.; Hilgers, L.A.T., 2000:
Oral immunization by food is less effective than intragastric immunization

Walters, N.; Rognlie, M.C.; Ascon, M.A.; Pascual, D.W., 2000:
Oral immunization of bison with an attenuated Salmonella vaccine vector induces mucosal and systemic immune responses against enterotoxigenic Escherichia coli K99 fimbriae

Salome,G.; Gowda,P.H.R., 2010:
Oral immunization of mice with rabies vaccine using different baits

Wedemeyer, H.; Gagneten, S.; Davis, A.R.; Feinstone, S.M.; Rehermann, B., 2000:
Oral immunization with HCV-NS3 encoding Salmonella Long-lasting induction of HCV-specific CTL in an HLA-A2 transgenic mouse model

Flanagan, M.P.; Michael, J.G., 1999:
Oral immunization with a Streptococcal pneumoniae polysaccharide conjugate vaccine in enterocoated microparticles induces serum antibodies against type specific polysaccharides

Hickey, D.K.; Aldwell, F.E.; Beagley, K.W., 2010:
Oral immunization with a novel lipid-based adjuvant protects against genital Chlamydia infection

Pinto, E.F.; Gattass, C.R.; Rodrigues, J.M.Jr.; Rossi Bergmann, B., 1999 :
Oral immunization with leishmanial antigens delays the onset of infection with L amazonensis

Rose, R.C.; Williamson,; Rybicki, E.P., 2000:
Oral immunization with papillomavirus virus-like particles

Arntzen, C.J.; Mason, H.S.; Haq, T.A., 2001:
Oral immunization with transgenic plants

Pozzilli, P., 1999:
Oral immunotherapy for diabetes prevention

Bier, Milan, 2000:
Oral immunotherapy of bacterial overgrowth

Mcguinness, C.M.; Burnside, B.A.; Rudnik, E.M., 1999:
Oral induction of tolerance to parenterally administered non-autologous polypeptides

Carnoy, C.; Muller Alouf, H.; Mullet, C.; Droy Lefaix, M.T.; Simonet, M., 2000:
Oral infection of mice with superantigenic toxin producing Yersinia pseudotuberculosis Effect of diosmectite

Trees, A.J.; Mcallister, M.M.; Guy, C.S.; Smith, R.; Williams, D.J.L., 2002:
Oral infection of pregnant cows with Neospora caninum oocysts

Liesenfeld, O.; Maletz, A.; Erb, K.; Hahn, H., 2000:
Oral infection with Toxoplasma gondii abrogates established Th-2 immune responses to Nippostrongylos brasiliensis

Lalla, E.; Lamster, I.B.; Spessot, A.L.; Lu, Y.; Papapanou, P.N.; Stern, D.M.; Schmidt, A.M.rie, 2000:
Oral infection with an established periodontal pathogen accelerates atherosclerosis in apo E null mice

Gibson, F.C.I.i; Hong, C.; Wang, J.; Genco, C.A., 2002:
Oral infection with invasive Porphyromonas gingivalis stimulates accelerated atherosclerotic plaque accumulation in ApoE-/- mice

Doerflinger, A.; Davis, R.J.; Swithers, S.E., 2000:
Oral infusions of corn oil emulsions do not affect independent ingestion in rat pups

Carrithers, J.A.; Gallagher, P.M.; Baier, S.M.; Trappe, S.W., 1999:
Oral ingestion of beta-hydroxy-beta-methylbutyrate Effects on hematology, hepatic and renal function

Darveau, Richard P., 2000:
Oral innate host defense responses Interactions with microbial communities and their role in the development of disease

Richardson, G.; O'byrne, S.; Mcknight, G.; Moore, K.; Benjamin, N., 2000:
Oral inorganic nitrate inhibits platelet function

Lewin, A.; Modi, P., 2000:
Oral insulin Metformin combination therapy for treatment of type-2 diabetes

Kapitza, C.; Arbit, E.; Abbas, R.; Goldberg, M.; Hompesch, M.; Heinemann, L.; Heise, T., 2003:
Oral insulin Proof of concept in Type 2 diabetic patients

Modi, P.; Guevara Aguirre, J.; Guevara, M.; Saavedra, J.; Moncayo, P.; Benitez, E.; Llore, L.; Baldeon, G., 2002:
Oral insulin spray as meal insulin for treatment of Type 1 diabetes

Schwaibold, H.E.; Popiel, C.; Geist, E.; Hartung, R., 2000:
Oral intake of poppy seed A reliable and simple method for diagnosis of vesicoenteric fistulas

Beilharz, M.W.; Bosio, E.; Seidler, A.L., 2001:
Oral interferon therapy and the innate/acquired axis

Grady, R.W.; Giardina, P.J., 1999:
Oral iron chelation A potential role for HBED in combination therapy

Pippard, M.J.; Weatherall, D.J., 2000:
Oral iron chelation therapy for thalassaemia: an uncertain scene

Bell, H.; Berg, J.P.; Undlien, D.; Distante, S.; Try, K.; Raknerud, N.; Heier, H.E.; Thomassen, Y.; Haug, E., 2000:
Oral iron intake for several years may induce hemochromatosis in patients without the HFE-gene C282Y mutation

Carrier, J.; Elaheh, A.; Cullen, J.; Allard, J.P., 2000:
Oral iron supplementation increase oxidative stress and colonic damage in DSS-induced rat model of colitis

D.S.lva, A.D.; Rampton, D., 2002:
Oral iron therapy does not exacerbate inflammatory bowel disease

Bachman, T.A.; Clare, T.; Serbinski, A., 2000:
Oral irrigator housing

Bettoli, V.; Borghi, A.; Pizzigoni, S.; D.S.nctis, V.; Virgili, A., 2004:
Oral isotretinoin for severe acne in beta-thalassemia major

Geraldine, P.; Kaliamurthy, J.; Thomas, P.A., 1999:
Oral itraconazole and fluconazole treatment for experimental aspergillosis

Namburi, R.R.ju; Kerr, J.E.gin, 2003:
Oral itraconazole formulations and methods of making the same

Chosidow, O.; Giraudeau, B.; Cottrell, J.; Izri, A.; Hofmann, R.; Mann, S.G.; Burgess, I., 2010:
Oral ivermectin versus malathion lotion for difficult-to-treat head lice

Kapur, N.; Friedman, R., 2002:
Oral ketamine: a promising treatment for restless legs syndrome

Romach, M.K.; Sellers, E.M.; Kaplan, H.L.; Fernandes, L.C.; Oldenhof, J.; Mcdonald, S., 2004:
Oral ketamine as a positive control in abuse liability studies

Vranken, J.H.; Pijl, A.J.; Van Der Vegt, M.R.; Eshuis, J.E., 2001:
Oral ketamine in patients with central pain

Coussons Read, M.E.; Tyler, R.C., 2000:
Oral l-arginine supplementation affects circulating cytokine levels and stress reactivity

Dunn, S.R.; Simenhoff, M.L.; Gaughan, W.J.; Eltayeb, B.O.; Ahmed, K.E.; Fitzpatrick, M.E.len D., 2000:
Oral lactobacillus acidophilus reduces blood levels of dimethylamine , a uremic toxin, and nitrosodimethylamine , a carcinogen in ESRD patients Potential use for probiotics in ESRD

de Castro, C.; Quirce, S.; Fernández-Nieto, M.; Sastre, J., 2002:
Oral latex glove allergy

Kalayoglu Besisik, S.; Ak, G.; Koray, M.; Savran Oguz, F.; Sargin, D.; Tanyeri, H., 2003:
Oral lesions and hygiene in stem cell recipients with graft versus host disease

Ramirez Amador, V.; Irigoyen, M.E.; Esquivel Pedraza, L.; Anaya Saavedra, G.; Gonzalez Ramirez, I.; Garcia, E.; Gonzalez Guevara, M., 2000:
Oral lesions in a group of Mexican individuals attending an HIV Screening Center

Patel, N.J.; Sciubba, J., 2003:
Oral lesions in young children

Lasko, B.; Lau, C.Y.; Anstey, R.J.; StPierre, C.; Martel, A.Y.; Diaz Mitoma, F.; Canadian Collaborative Sinusitis Study Group, 1999:
Oral levofloxacin compared with clarithromycin in acute sinusitis

Chaiyarit, P.; Kafrawy, A.H.; Miles, D.A.; Zunt, S.L.; Van Dis, M.L.; Gregory, R.L., 1999:
Oral lichen planus An immunohistochemical study of heat shock proteins and cytokeratins and a unifying hypothesis of pathogenesis

Kolde, G.; Wesendahl, C.; Stein, H.; Reichart, P.A., 2003:
Oral lichen planus: diagnostic immunofluorescence testing on routine histological material

Ido, T.; Kumakiri, M.; Kiyohara, T.; Sawai, T.; Hasegawa, Y., 2002:
Oral lichen planus due to zinc in dental restorations

Pecegueiro, M.; Sachse, M.F.; Amaro, J.; Farinha, P.; Fonseca, I., 1999:
Oral lichen planus versus oral lichenoid eruption as a manifestation of contact allergy

Auzerie, V.; Mahé, E.; Marck, Y.; Auffret, N.; Descamps, V.; Crickx, B., 2001:
Oral lichenoid eruption due to methacrylate allergy

Akihiro, Yoshiaki, 2003:
Oral lip and chin muscle rehabilitating device

Keller, Brian C., 2004:
Oral liposomal delivery system

Skrabanja, A.T.tus Philip; Tully, R.E.ward, 2000:
Oral liquid antidepressant solution

Wilson, E.S.; Trespidi, L.A.; Clark, C.M.; Desai, A.J.; Meyer, G.A., 2001 :
Oral liquid compositions

Bahal, S.M.; Maurin, M.B., 2001:
Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors

Tully, Roger Edward, 2000:
Oral liquid medicine solution

Dobrozsi, Douglas Joseph, 2003:
Oral liquid mucoadhesive compositions

Dobrozsi, Douglas Joseph, 2001:
Oral liquid mucoadhesive compounds

Kobayashi, R.; Zemlin, M.; Kataoka, K.; Zemlin, C.; Schelonka, R.; Dimmitt, R.; Hino, A.; Schroeder, H.W.J.; Mcghee, J.R.; Fujihashi, K., 2003:
Oral live r-Salmonella expressing fragment C of tetanus toxin induces antigen-specific IgA responses in mice with limited Igh variable region diversity

Boriani, G.; Martignani, C.; Biffi, M.; Capucci, A.; Branzi, A., 2002:
Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment

Hunter, C.M.; Gaffar, A.; Mordarski, T.D., 2000:
Oral lubricating composition

Wang, T.; Steel, G.; Valle, D., 2001:
Oral lysine supplementation reduces plasma ornithine in a mouse model of gyrate atrophy of the choroid and retina

Zehender, M.; Faber, T.S.; Manz, M.; Susilo, R., 2001:
Oral magnesium and potassium treatment of frequent ventricular tachyarrhythmias Lessons from the MAGICA trial

Standley, C.; Daugherty, M.; Lohff, J., 2001:
Oral magnesium does not alter brain levels of ionized magnesium in pregnant rats

Chagas, E.H.; Kelly, D.G.; Camilleri, M.; Burritt, M.F., 2003:
Oral magnesium gluconate increases urinary mg2+ in patients with short bowel syndrome

Wang, F.; Van Den Eeden, S.; Ackerson, L.; Salk, S.; Reince, R., 2000:
Oral magnesium oxide prophylaxis of frequent childhood migraine

Shechter, M.; Merz, C.N.el Bairey; Stuhlinger, H.S.; Sharir, M.; Matezki, S.; Pachinger, O.; Slany, J.; Rabinowitz, B., 2001:
Oral magnesium supplementation improves exercise duration and quality of life in patients with coronary artery disease

Shechter, M.; Bairey Merz, C.N.; Paul Labrador, M.; Meisel, S.R.; Molloy, M.D.; Rude, R.K.; Shah, P.K.; Kaul, S., 1999:
Oral magnesium treatment inhibits platelet-dependent thrombosis in patients with coronary artery disease

Shirley, J.C.; Thornton, J.B., 2000:
Oral manifestations of Langerhans' cell histiocytosis: review and report of case

Sierevogel, M.J.; Pasterkamp, G.; Velema, E.; D.K.eijn, D.P.V.;, B.J.G.L.; D.J.egere, P.P.T.; Borst, C., 1999:
Oral matrix metalloproteinase inhibition following balloon angioplasty in a non-atherosclerotic pig model

Bartholomaeus, J.; Betzing, J., 2001:
Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates

Palumbo, A.; Bertola, A.; Musto, P.; Nunzi, M.; D.S.efano, V.; Callea, V.; Rotoli, B.; Petti, M.C.; Caravita, T.; Lauta, V.M.; Patti, C.; Bringhen, S.; Cavallo, F.; Falco, P.; Carella, A.M.; Liberati, A., 2003:
Oral melphalan, Prednisone and Thalidomide for newly diagnosed myeloma

Woo, J.S.o; Suh, H.J.o, 2002:
Oral micro-emulsion composition of silybin

Desoto, J.S.garra; Torres, R.V.zquez; Rodriguez Duran, A., 1999:
Oral microbiota of bats

Johnson, T.N.; Rostami Hodjegan, A.; Tucker, G.T., 2002:
Oral midazolam for sedation in children A pharmacokinetic-pharmacodynamic analysis

Millet, C.; Ogden, F.; Lutz, B., 2000:
Oral minocycline without long-term intravenous antibiotics for treatment of prosthetic joint infections

Delaney, T.; Crane, J.M.; Hutchens, D.; Fanning, C.A.; Young, D.C., 2001:
Oral misoprostol labor induction in patients with a favorable cervix

Crane, J.; Delaney, T.; Hutchens, D., 2002:
Oral misoprostol labor induction in term prelabor membrane rupture

Tortora, G.; Damiano, V.; Bianco, R.; Fontanini, G.; Caputo, R.; Bianco, A.R.; D.P.acido, S.; Agrawal, S.; Ciardiello, F., 1999:
Oral mixed-backbone oligonucleotide targeting protein kinase A causes inhibition of growth, angiogenesis and growth factor production and cooperative antitumor activity with cytotoxic drugs in human cancer xenografts

Stark, P.; Cunningham, S.; Moodley, J., 2000:
Oral morphine multiparticulate formulation

Braddock, B.A.; Braddock, S.R.; Maria, B.L., 2003:
Oral motor findings in Joubert syndrome

Solomon, B.I.; Mccullagh, L.; Krasnewich, D.; Smith, A.C.M.; Sms Research Unit, 2002:
Oral motor, speech and voice functions in Smith Magenis Syndrome children A research update

Rakhmatov, T.P.; Irsaliev, K.I., 2001:
Oral mucosa in patients with lichen ruber planus

Hannu, L.; Markku, V.; Pekka, V.; Stina, S.; Markku, M., 2000:
Oral mucosa responds by recruitment and non-proliferative activation of T cells after submucosal challenge with a gliadin derived peptide

Buser, Thomas, 2001:
Oral mucosal composition comprising 5-aminosalicylic acid

Zhang, H.; Zhang, J.; Streisand, J.B., 2002:
Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications

Stancliff, S.; Abel, S.; Agins, B., 2001:
Oral mucosal lesions and HIV viral load in the Womens Interagency HIV Study

Epstein, J.B.; Schubert, M.M., 1999:
Oral mucositis in myelosuppressive cancer therapy

Durrant, S.; Pico,; Ford, J.M., 2001:
Oral mucositis reduced health related quality-of-life in a phase 1 trial of lymphoma patients receiving high-dose chemotherapy with autologous PBPC transplantation

Oldenburg, B.; Van Berge Henegouwen, G.P.; Koningsberger, J.C., 1999:
Oral mycophenolate mofetil in the treatment of inflammatory bowel disease

Lima Júnior, S.Monteiro.; Asprino, L.; Prado, A.Pedro.; Moreira, R.Willian.Fernandes.; de Moraes, Márcio., 2010:
Oral myiasis caused by Cochliomyia hominivorax treated nonsurgically with nitrofurazone: report of 2 cases

Terg, R.; Coronel, E.; Sorda, J.; Findor, J., 2000:
Oral naltrexone treatment for cholestatic pruritus A randomized, double blind, crossover study

Jakobi, P.; Solt, I.; Weiner, Z.; Zimmer, E.Z.Z., 1999:
Oral narcotic and non-narcotic analgesia after cesarean section

Fujita, T.; Kosugi, K.; Ueda, N.; Hatano, M., 2001:
Oral nateglinide administration improves glycemic control of type 2 diabetic patients, treated with intermediate-acting insulin

Iliodromitis, E.K.; Bofilis, E.; Zoga, A.; Steliou, I.; Vrettou, R.; Cokkinos, P.; Kremastinos, D.T.H., 2002:
Oral nicorandil recaptures the waned protection of preconditioning in vivo

Liu, R.; Mizuta, M.; Ueno, H.; Shiiya, T.; Suefuji, M.; Matsukura, S., 2001:
Oral nicotine administration decreases insulin resistance in obese rats

Wilmouth, C.; Spear, L.P., 2002:
Oral nicotine self-administration in rats during adolescence

Cook, T.A.; Smilgin Humphreys, M.M.; Mortensen, N.J.M.c, 1999:
Oral nifedipine effectively reduces resting anal pressure A potential new treatment for anal fissures

Dawood A.W.ili, N.S.; A.J.bouri, K.Y., 2001:
Oral nifedipine in the treatment of primary tonic clonic epilepsy

Reitz, Aé.; Knapp, P.A.; Müntener, M.; Schurch, B., 2004:
Oral nitric oxide donors: a new pharmacological approach to detrusor-sphincter dyssynergia in spinal cord injured patients?

Reitz, A.; Knapp, P.; Schurch, B., 2003 :
Oral nitric oxide for treatment of detrusor-sphincter dyssynergia in spinal cord injured patients

Tamaki, T.; Kirima, K.; Okamoto, M.; Kondo, S.; Kagami, S.; Yoshizumi, M.; Tsuchiya, K., 2003:
Oral nitrite increases the blood nitric oxide levels and protects L-name-induced renal injury in rats

Pongsiriwet, S.; Iamaroon, A.; Mahanupab, P.; Kitikamthon, R.; Pintong, J., 2002:
Oral non-Hodgkins lymphomas p53 expression and lack of EBV expression

Edington, J.; Hollingsworth, M.; Rhoades, L.; Campbell, S.; Ferguson, M.; Mayer, K.; Voss, A., 2002:
Oral nutritional supplement flavour preferences of weight-losing patients with cancer

Verma, S.; Kirkwood, B.; Brown, S.; Giaffer, M.H., 2001:
Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease

Nugent, A.G.; Wolthers, T.; Kam, G.; Leung, K.C.; Garrett, C.; Ho, K.K.Y., 2000:
Oral oestrogen opposes the growth hormone -induced rise in extracellular water

Alemany, M.; Grasa, M.M.; Esteve, M.; Masanes, R.M.; Yubero, P.; Blay, M.; Lopez Marti, J.; Cabot, C.; Vila, R.; Fernandez Lopez, J.A.; Remesar, X., 2000:
Oral oleoyl-estrone effects on insulin resistance of Zucker obese rats

Alemany, M.; Fernandez Lopez, J.A.; Petrobelli, A.; Granada, M.; Foz, M.; Remesar, X., 2002:
Oral oleoyl-estrone-induced loss of weight in a morbidly obese man

Lagranderie, M.; Chavarot, P.; Balazuc, A.M.; Marchal, G., 1999:
Oral or intragastric administration of BCG induced immune responses and protection against tuberculosis

Lowell, George H., 1999:
Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides

Cunha, B.A., 2001:
Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia

Von Falkenhausen, Christian, 2003:
Oral or mucosal preparation containing an active ingredient, with controlled active ingredient release, and its use

E.Rafaey, Hazem, 2003:
Oral or vaginal administration of mesoprostol in third stage labor

Tielemans, W.M.J., 2002:
Oral orthesis to reduce snoring and sleep apnea symptoms

Reeda, C.F.; Markwell, P.J.; Jones, C.A.; Mayer, R.J.; Smith, B.H.E., 2000:
Oral orthophosphate salt administration, and its effect on feline urinary calcium oxalate formation and agglomeration

Hayden, F.G.; Ward, P.; Roberts, N., 2000:
Oral oseltamivir in experimental human influenza B virus infection Lack of resistance emergence

Hayden, F.; Belshe, R.; Villanueva, C.; Lanno, R.; Small, I.; Hughes, C.; Dutkowski, R., 2002:
Oral oseltamivir prevents the spread of influenza between children in households

Kurowski, M.; Barrett, J.; Waalberg, E.; Wiltshire, H., 2000:
Oral oseltamivir rapidly delivers active drug levels to middle ear and sinuses in humans

Kaiser, L.; Ward, P.; Mahoney, P.; Hayden, F.G., 2001:
Oral oseltamivir reduces complications and hospitalizations resulting from influenza infection A meta-analysis

Winther, B.; Hayden, F.G.; Whitley, R.; Reisinger, K.; Dutkowski, R.; Ipe, D.; Ward, P.; Mills, R., 2000:
Oral oseltamivir reduces the risk of developing acute otitis media following influenza infection in children

Puthli, S.P.; Menon, S.G.; Karajgi, J.S.; Dharmadhikari, N.B.; Shrivastava, R.H.; Pilgaonkar, P.S., 2003:
Oral osmotic controlled drug delivery system for a sparingly soluble drug

Grover, J.; Caravati, E.M., 2000:
Oral overdose of N-acetylcysteine in an infant

Just, T.; Steiner, S.; Pau, H.W., 2010:
Oral pain perception and taste in burning mouth syndrome

Iglesias Garcia, J.; Iglesias Garcia, M.; Iglesias Rey, M.; Dominguez Munoz, E., 2003:
Oral pancreatic enzyme supplementation in patients with exocrine pancreatic insufficiency is it enough to evaluate clinical response?

Pisegna, J.R.; Forsmark, C.E.; Soffer, E.; Bochenek, W.J.; Metz, D.C., 2000:
Oral pantoprazole effectively controls gastric acid output in Zollinger-Ellinson syndrome and idiopathic hypersecretion

Metz, D.C.; Forsmark, C.E.; Soffer, E.; Bochenek, W.J.; Pisegna, J.R., 2000:
Oral pantoprazole effectively maintains control of acid output in Zollinger-Ellison syndrome and idiopathic hypersecretion

Richter, J.; Bochenek, W., 1999:
Oral pantoprazole treatment decreases antacid usage in patients with symptomatic erosive esophagitis

Shen, W-Chiang., 2003:
Oral peptide and protein delivery: unfulfilled promises?

Stern, W.; Gilligan, J.P., 2000:
Oral peptide pharmaceutical products

Sachs, G.; Dietrich, R., 2000:
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole

Sachs, G.; Dietrich, R., 2000:
Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors

Valenti, Mauro, 2002:
Oral pharmaceutical compositions containing buprenorphin

Aylwin,; Banbury, S.; Ferdinando, Christine; D.N.js, H., 2003:
Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants

Depui, H.; Rosinski, A., 2000:
Oral pharmaceutical dosage form

Depui, H.; Lundberg, P., 2003:
Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID

Depui, H.; Hallgren, A., 2000:
Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent

Depui, H.; Hallgren, A., 2001:
Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate

Midha, K.K.; Hirsh, M.; Lo,, 2002:
Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent

Birrenbach, G.; Juch, R.D.eter, 1999:
Oral pharmaceutical preparation containing erythromycin base

Mockel, J.; Gabel, R.D.eter; Woog, H., 2000:
Oral pharmaceutical preparation containing ibandronat

Chen, G.L.n; Hsu, W.Y., 2001:
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same

Lundberg, P.J.han; Sjoblom, B., 2003:
Oral pharmaceutical pulsed release dosage form

Winegarden, K.L.; Ciesla, S.L.; Aldern, K.A.; Beadle, J.R.; Hostetler, K.Y., 2002:
Oral pharmacokinetics and preliminary toxicology of 1-O-hexadecyloxypropyl-cidofovir in mice

Trahan, J.; Ciesla, S.L.; Winegarden, K.L.; Hostetler, K.Y., 2003:
Oral pharmacokinetics and tissue distribution of 1-O-hexadecyloxypropyl- cyclic cidofovir in mice

Sharma, V.K.; Spears, T.; Peyton, B.; Raufman, J.P.erre; Howden, C.W., 2000:
Oral pharmacokinetics of lansoprazole after single and multiple doses as intact capsule and as simplified lansoprazole suspension

Ho, J.C.; Meier, J.L.; Lopez, J.R.; Cunningham, F.; Swislocki, A.L.M.; Noth, R.H.; Siegel, D., 2002:
Oral pharmacological treatment of type 2 diabetes mellitus in veterans

Burnett, A.L., 1999:
Oral pharmacotherapy for erectile dysfunction: current perspectives

Brock, Gerald, 2000:
Oral phentolamine

Domrongkitchaiporn, S.; Disthabanchong, S.; Cheawchanthanakij, R.; Niticharoenpong, K.; Stitchantrakul, W.; Charoenphandhu, N.; Krishnamra, N., 2010:
Oral phosphate supplementation corrects hypophosphatemia and normalizes plasma FGF23 and 25-hydroxyvitamin D3 levels in women with chronic metabolic acidosis

McCarty, M.F.; Barroso-Aranda, J.; Contreras, F., 2010:
Oral phycocyanobilin may diminish the pathogenicity of activated brain microglia in neurodegenerative disorders

Arroyave, C.P.; Scott, I.U.; Fernandez, V., 2003:
Oral pilocarpina for dry eye in sjogrens syndrome

Angulo, P.; Maccarty, R.L.; Sylvestre, P.B.; Jorgensen, R.A.; Larusso, N.F.; Lindor, K.D., 2000:
Oral pirfenidone in the treatment of primary sclerosing cholangitis

Oguchi, S.; Nosaka, T.; Nagao, K.; Satou, K.; Yumi, K.; Watanabe, I.; Yamashita, M.; Watanabe, M.; Shioiri, K.; Kikushima, K.; Arima, K.; Arima, K., 1999:
Oral platelet glycoprotein IIb/IIIa antagonist decreased intimal thickening after arterial injury in hypercholesterolemic apolipoprotein E knockout mice

Kereiakes, D.J., 1999:
Oral platelet glycoprotein IIb/IIIa inhibitors

Sawyer, M.H.; Saez Llorenz, X.; Aviles, C.L.z; O'ryan, M.; Romero, J.R., 1999:
Oral pleconaril reduces the duration and severity of enteroviral meningitis in children

Anonymous, 2000:
Oral poliovirus was not the source of HIV-1

Cesaretti, M.L.R.; Ginoza, M.; Shiguehara, F.; Kohlmann, N.E.B.; Tavares, A.; Zanella, M.T.; Ribeiro, A.B.; Kohlmann, O., 2000:
Oral potassium overload reduces blood pressure and improves glucose metabolism in spontaneously hypertensive rats

García-Lerma, J.Gerardo.; Paxton, L.; Kilmarx, P.H.; Heneine, W., 2010:
Oral pre-exposure prophylaxis for HIV prevention

Sudbo, J.; Kildal, W.; Sondresen, J.E.; Ristimaki, A.; Nesland, J.M.; Reith, A.; Bryne, M., 2002:
Oral precancer Risk assessment in a chemopreventive perspective

Caon, C.; Ching, W.; Tselis, A.; Lisak, R.; Khan, O., 2003:
Oral prednisone taper has no effect on neurologic recovery following intravenous methylprednisolone for the treatment of an MS relapse

Million, M.; Wang, L.; Maryanov, T.; Coutinho, S.; Mayer, E.; Tache, Y., 2001:
Oral pregabalin reduces repeated colorectal distention -induced visceral pain and lumbosacral spinal cord neuronal activation in rats

Varma, A.K., 1999:
Oral premalignant lesions in rural Indian inhabitants

Spong, C.; Vink, J.; Auth, J.; Gozes, I.; Brenneman, D., 2001:
Oral prenatal treatment with peptides increases adult performance in a learning paradigm

Cremer, Karsten, 2001:
Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium

Stoilov, I.L.bomirov; Georgiev, T.D.mitrov; Taskov, M.V.silev; Koleva, I.D.mitrova, 1999:
Oral preparation for patients with chronic renal insufficiency, method of making and use

Wadstrom, T.; Alejung, P., 2001:
Oral preparation for the prophylactic and therapeutic treatment of Helicobacter sp infection

Ren, G.; Fei, G., 2003:
Oral preparation of coenzyme a useful for lowering blood lipid and a method producing for same

Murata, M.; Saito, Y.; Kanbe, H.; Yamauchi, S.; Iwasa, A., 2002:
Oral preparations comprising S- -L-cysteine

Komuro, C.; Yahiro, T.; Yoshida, H., 2002:
Oral preparations containing forskolin derivatives and process for producing pharmaceutical preparations

Brooke, A.E.; Eveson, J.W.; Luker, J.; Oakhill, A., 1999:
Oral presentation of a novel variant of herpes simplex infection in a group of bone marrow transplant patients: a report of five cases

Ray, N.B.; Krieg, A.M., 2001:
Oral pretreatment of mice with immunostimulatory CpG DNA induces reduced susceptibility to Listeria monocytogenes

Stewart, R.A.; Pelican, K.M.; Brown, J.L.; Wildt, D.E.; Ottinger, M.A.; Howard, J.G., 2010:
Oral progestin induces rapid, reversible suppression of ovarian activity in the cat

Villani, G.Q.; Piepoli, M.F.; Marrazzo, N.; Rosi, A.; Capucci, A., 2001:
Oral propafenone cost-effectiveness in patients with recent onset atrial fibrillation

Peterson, K.S.; Sherman, J.M.; Chilcott, C.; Wu,, 2001:
Oral prophalaxis paste

Meggs, W.J.; Freeman, J.M.Jr, 1999:
Oral prophylaxis of organophosphate poisoning in mice

Bagnis, C.; Berutti, S.; Vitale, C.; Marangella, M.; Tricerri, A.; Bruno, M.; Petrarulo, M.; Ramello, A., 2002 :
Oral protein supplements in CAPD Medium term evaluation of nutritional markers

Holm, L.; Esmarck, B.; Suetta, C.; Matsumoto, K.; Mizuno, M.; Kjaer, M., 2003:
Oral protein/carbohydrate increases muscle protein balance following resistance exercise in postmenopausal women

Vocks, E.; Fornoff, N.; Rakoski, J.; Ring, J., 2001:
Oral provocation test with fragrances in fragrance-sensitized subjects

Giehtbrock, K.; Flynn, S.; Andrist, D.; Mccready, L.; Frigas, E., 1999:
Oral provocation testing with common dyes and preservatives used by the food industry Our experience over the last five years

Vieluf, D.; Wieben, A.; Ring, J., 1999:
Oral provocation tests with food additives in atopic eczema

D.V.sser, M.; Van Der Meulen, M.F.G.; Hoogendijk, J.E.; Burger, H.; Wokke, J.H.J., 2001:
Oral pulsed dexamethasone or prednisone for idiopathic inflammatory myopathies Prospective long-term follow-up in 16 patients

Burnside, B.A.; Guo, X.; Fiske, K.; Couch, R.A.; Treacy, D.J.; Chang, R.K.n; Mcguinness, C.M.; Rudnic, E.M., 2003:
Oral pulsed dose drug delivery system

Hernández-Martín, A.; Arias-Palomo, D.; Hermida, G.; Gutiérrez-Ortega, M.C.; Ramírez-Herrera, M.; Rodríguez-Vegas, M.; Velasco, A., 2003:
Oral pyoderma gangrenosum

Sun, G.Y.; Xu, J.; Zhang, Z.; Shen, S.; Von Borstel, R.W.; Saydoff, J.A., 2000:
Oral pyrimidine treatment protects against neuronal loss in the gerbil stroke model

Saydoff, J.A.; Liu, L.S.; Von Borstel, R.W., 2000:
Oral pyrimidine treatment protects mice against striatal damage and behavioral impairment induced by 3-nitropropionic acid

Williamson, L.; Illingworth, H.; Smith, D.; Mowat, A., 2000:
Oral quinine in ankylosing spondylitis: a randomized placebo controlled double blind crossover trial

King, R.; Yakobson, B.; David, D.; Zamir, S.; Linhart, S.B.; Naveh, U.; Fridman, J., 2000:
Oral rabies vaccination of wildlife in Israel

Waksman, R.; Ajani, A.E.; Pichard, A.D.; Pinnow, E.; Satler, L.F.; Kent, K.M.; Weissman, N.J.; Torguson, R.; Gambone, L.; Abbott, M.; Iloanya, P.; Lindsay, J., 2003:
Oral rapamune to inhibit restenosis in patients with multi de-novo coronary lesions requiring stenting

Pakala, R.; Burnett, M.S.san; Gulick, C.P.; Fournadjiev, J.; Leborgne, L.; Cheneau, E.F.; Hellinga, D.; Epstein, S.E.; Waksman, R., 2003:
Oral rapamycin attenuates progression of atherosclerotic plaque in ApoE knockout mice

Mehran, R.; Marx, S.; Kesanakurthy, S.; Adamian, Y.; Aboufares, A.; Moussa, I.; Kokolis, S.; Collins, M.; New, G.; Polena, S.; Cosico, J.; Lansky, A.J.; Moses, J.W.; Stone, G.W.; Leon, M.B.; Dangas, G., 2003:
Oral rapamycin for the prevention of in-stent restenosis

Rodriguez, A.E.; Rodriguez Alemparte, M.; Fernandez Pereira, C.; Vigo, C.F.; Llaurado, C.; Russo Felsen, M.; Pocovi, A.; Vetcher, D., 2004:
Oral rapamycin in patients undergoing coronary stent therapy Final results of the ORAR Study

Tyler, K.R.; Venkova, K.; Keith, J.C.Jr.; Albert, L.; Greenwood Van Meerveld, B., 2001:
Oral recombinant human interleukin-11 normalizes epithelial transport in the colon of HLA-B27 rats with spontaneous colitis

Van Scott, M.; Glynn, P.; Varadhachary, A., 2004:
Oral recombinant human lactoferrin in a non-human primate model of asthma

Huang, Chang Lung, 2003:
Oral rehabilitation device

Guarino, A., 2000:
Oral rehydration for infantile diarrhoea: toward a modified solution for the children of the world

Michell, A.R., 2010:
Oral rehydration: measuring what matters

Santosham, M., 2002:
Oral rehydration therapy: reverse transfer of technology

Anidi, Ifeoma E., 2000:
Oral rehydration therapy in diarrhea Parental knowledge and practices

Bellemare, S.; Hartling, L.; Wiebe, N.; Russell, K.; Craig, W.; Klassen, T.P., 2002:
Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children A systematic review

Ozuah, P.O.; Avner, J.R.; Stein, R.E.K., 2001:
Oral rehydration, practice parameters, and emergency physicians A national survey

Matsumoto, T.; Taguchi, Y.; Fujita, K.; Ametani, A.; Kaminogawa, S.; Nakagami, M., 2000:
Oral remedy for rheumatoid arthritis and functional food

Fujiu, K.; Manabe, I.; Oishi, Y.; Tsushima, K.; Nishimura, G.; Nagai, R., 2003:
Oral retinoic acid receptor alpha agonist inhibits in-tent restenosis

Kligerman, A.E.; Rogers, S., 2002:
Oral rinse methods and compositions

Volkow, N.D.; Wang, G.J.; Fowler, J.S.; Gerasimov, M.R.; Gatley, J.S.; Gifford, A.; Logan, J.; Pappas, N.; Wong, C.; Franceschi, M.; Dewey, S.L.; Ding, Y.S.; Franceschi, D., 2000:
Oral ritalin increases dopamine concentration in human brain

Kuiken, S.; Van Den Berg, S.; Tytgat, G.; Boeckxstaens, G., 2003:
Oral s ketamine increases visceral sensitivity in healthy volunteers

Khoury, S.J.; Comabella, M.; Weiner, H.L., 1999:
Oral salbutoamol decreases interleukin-12 expression in monocytes of patients with multiple sclerosis

Stern, W.; Gilligan, J.P., 1999:
Oral salmon calcitonin pharmaceutical products

Fabian, T.J.; Ujhelyi, M.R.; Schwartzman, D.S.; Bigos, K.L.; Corey, S.E.; Kroboth, P.D., 2003:
Oral sedation improves patient perception of shock delivery with an implantable atrial defibrillator

Masini, C.V.; Maki, A.C.; Baek, J.H.; Spires, S.S.; Holmes, P.V., 2003:
Oral self - administration of amphetamine is increased in the olfactory bulbectomized rat model of depression

Knippels, L.M.J.; Penninks, A.H.; Houben, G.F., 1999:
Oral sensitization to food proteins A Brown Norway rat food allergy model

Knippels, L.M.J.; Van Wijk, F.; Penninks, A.H., 2000:
Oral sensitization to peanut proteins A Brown Norway rat food allergy model

Grainger, B.T.; Kleinhenz, R.J.; Christensen, G.W., 2002:
Oral sensory perception-affecting compositions containing dimethyl sulfoxide, complexes thereof and salts thereof

Pierce, A.; Koumans, E.; Sawyer, M.; Akers, C.; Black, C.; Markowitz, L., 2001:
Oral sex as an indicator of high risk behavior

Michelakis, E.D.; Tymchak, W.; Lien, D.; Dasilva, L.; Hashimoto, K.; Archer, S.L., 2002:
Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension

Kaplan, B.; Ben-Rafael, Z.; Peled, Y.; Bar-Hava, I.; Bar, J.; Orvieto, R., 1999:
Oral sildenafil may reverse secondary ejaculatory dysfunction during infertility treatment

Zelek, L.; Barthier, S.; Riofrio, M.; Sevin, D.; Spielmann, M., 2000:
Oral single-agent estramustine is active in advanced breast cancer after failure with anthracyclines and taxanes

Teirstein, P.S.; Moses, J.W.; Fernandez, M.R.; Brara, P.; Grise, M.A.; Moussavian, M.; Reilly, J.P.; Leon, M.B., 2002:
Oral sirolimus for recalcitrant in-stent restenosis

Hausleiter, J.; Kastrati, A.; Mehilli, J.; Schuehlen, H.; Dotzer, F.; Goos, C.; Pogatsa Murray, G.; Vogeser, M.; Breuer, M.; Dirschinger, J.; Schoemig, A.; The Osiris Study Group, 2004:
Oral sirolimus to inhibit recurrent in-stent stenosis The randomized, double-blind, placebo-controlled OSIRIS trial

Costantini, C.R.; Zanuttini, D.; Tarbine, S.; Darwich, R.; Lazarte, J.L.; Costantini, C.O.; Maranhao, M.; Andrade, M.; Oliveira, M.R.; Sabattini, L.; Yared, G.; Bub, 2003:
Oral sirolimus to prevent restenosis after stenting de novo coronary lesions

Calhoun, D.A.; Renfroe, K.; Alper, A.B., 2000:
Oral sitaxsentan, an endothelin-A selective receptor antagonist, reduces systemic blood pressure in patients with mild-to-moderate primary hypertension

Kajimoto, O.; Sakamoto, W.; Odanaka, W.; Yoshida, K., 2003:
Oral skin improving agent, skin improving method, and food composition for improving skin

Curran, M.P.; Plosker, G.L., 2004:
Oral sodium phosphate solution: a review of its use as a colorectal cleanser

Schanz, S.; Kruis, W.; Mickisch, O.; Kueppers, B.; Hornung, A.; Buch Noethe, S.; Clement, T.; Boerner, N.; Berg, P., 2003:
Oral sodium phosphate solution versus polyethylene glycol based lavage for bowel preparation for colonoscopy a multicenter trial

Roser, B.J.; Blair, J.; Colaco, C.; Hatley, R.H.nry Morris, 1999:
Oral solid dosage forms, methods of making same and compositions thereof

Schiavino, D.; Buonomo, A.; Del Ninno, M.; Roncallo, C.; Pollastrini, E.; Camerini, A.; Nucera, E.; Patriarca, G., 2001:
Oral specific desensitization and immunologic modifications in 4 children with milk allergy

Cavallo, M.G.; Coppolino, G.; Romeo, S.; Manfrini, S.; Modi, P.; Pozzilli, P., 2001:
Oral spray insulin in patients with type 1 diabetes Comparison with regular insulin

Cavallo, M.G.; Coppolino, G.; Romeo, S.; Modi, P.; Parravano, M.C.; Pozzilli, P., 2001:
Oral spray insulin in patients with type 1 diabetes and residual beta cell function

Brandwein, M.; Teixeira, M.; Rolnitzky, L.; Lewis, C.; Lee, B.; Urken, M.; Wang, B., 2003:
Oral squamous carcinoma Invasion pattern and margin status correlate with locoregional recurrence

Gelman Keiles, D.; Lozada Nur, F., 2000:
Oral squamous cell carcinoma Where is the delay in diagnosis occurring?

Bernstein, K.S.; Schelling, S.H., 1999:
Oral squamous cell carcinoma in a coyote

Griff, J., 2001:
Oral steroids and inflammatory markers in asthma

Fucile, S.; Gisel, E.; Lau, C., 2002:
Oral stimulation accelerates the transition from tube to oral feeding in preterm infants

Hagiwara, Hidenori, 2002:
Oral stimulator

Dijkgraaf Ten Bolscher, M.; Neele, S.J.M.; Barto, R.; Netelenbos, J.C.; Van Der Vijgh, W.J.F., 2000:
Oral strontium as a test for intestinal calcium absorption Variation, validation, application

Rajendran, R., 2000:
Oral submucous fibrosis An Asiatic enigma

Frucht, H.; Movsas, B.; Hanlon, A.L.; Goosenberg, E.; Hoffman, J.; Cooper, H.; Lanciano, R.; Lee, W.R.; Schultheiss, T.; Hanks, G.E., 1999:
Oral sucralfate reduces the late GI effects of conformal RT for prostate CA A double-blind placebo-controlled randomized trial

Oberlander, T.F.; Grunau, R.E.; Hiddink, F.; Maaskant, R.; Fitzgerald, C.E.; Ling, E.; Whitfield, M.F., 2002:
Oral sucrose in the preterm infant Analgesic or behavioral modifier?

E.H.ddad, M.; Ross, M., 2001:
Oral sucrose stimulates ingestive behavior in near term ovine fetus

Cavallaro, L.G.; Moussa, A.M.; Caruana, P.; Merli, R.; Bertolini, S.; Iori, V.; Cavestro, G.M.; Muzzetto, P.; Liatopoulou, S.; Dal Bo, N.;, F., 2003:
Oral sucrose test and serum pepsinogens for evaluation of H pylori chronic gastritis

Gambaro, G.; DiN.A.S.G.oup, 2000 :
Oral sulodexide reduces albuminuria in type 1 and type 2, micro- and macro-albuminuric diabetic patients The DiNAS trial

Keith, A.D.; Gaisford, K.N.; Miller, A.H., 2004:
Oral supplement composition containing a plurality of mushroom strains

Chez, M.G.; Tremb, R.J.; Zenchak, J., 2001:
Oral supplementation of beta-hydroxybutyrate in rats

Van Weerden, W.M.; D.R.dder, C.M.; Bolder, C.A.; Wildhagen, M.; Kraemer, K.; Schroder, F.H., 2003:
Oral supplementation of vitamin E and lycopene reduces orthotopic growth of PC-346C prostate tumors

Turck, D.; Schmelmer, V., 2001:
Oral suspension of pharmaceutical substance

Wöhrl, S.; Hemmer, W.; Focke, M.; Götz, M.; Jarisch, R., 2001:
Oral symptoms due to zinc as a minor component of dental amalgam

Meer, S.; Coleman, H.; Altini, M., 2003:
Oral synovial sarcoma A report of two cases and a review of the literature

Berkhoudt, H.; D.B.kker, M.A.G.; Zweers, G.A., 2001:
Oral taste buds in the rattlesnake

Yu, D.; Walker, P.S.; Tang Liu, D., 2004:
Oral tazarotene does not affect the pharmacokinetics or efficacy of oral contraceptives

Tellier, G.; Lasko, B.; Leroy, B.; Sidarous, E.; Andrade, C., 2000:
Oral telithromycin for 5 days and 10 days is well tolerated and as effective as amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis in adults

Deabate, C.A.; Heyder, A.; Leroy, B.; Sidarous, E.; Backstrom, J., 2000:
Oral telithromycin for 5 days is well tolerated and as effective as cefuroxime axetil for 10 days in adults with acute exacerbations of chronic bronchitis

Ziter, P.; Quinn, J.; Leroy, B.; Sidarous, E.; Belker, M., 2000:
Oral telithromycin for 5 days is well tolerated and as effective as clarithromycin for 10 days in group A beta-hemolytic streptococcal pharyngitis/tonsillitis

Pullman, J.; Leroy, B., 2002:
Oral telithromycin for 7 to 10 days is as effective as standard comparators for the treatment of community-acquired pneumonia

Van Rensburg, D.; Moola, S.; Hagberg, L.; Rangaraju, M.; Leroy, B., 2001:
Oral telithromycin for 7-10 days is as effective as standard comparators for the treatment of community-acquired pneumonia

Pullman, J.; Champlin, J.; Leroy, B.; Sidarous, E., 2000:
Oral telithromycin for 7-10 days is well tolerated and as effective as oral trovafloxacin for 7-10 days in community-acquired pneumonia in adults

Tellier, G.; Hassman, J.; Leroy, B.; Sidarous, E.; Youngblood, D., 2000:
Oral telithromycin is well tolerated and as effective as oral clarithromycin in community-acquired pneumonia in adults

D.Berker, D., 2001:
Oral terbinafine treatment for toenail onychomycosis

Lefever, S.L.; Reddy, U.P.; Babaliaros, V.C.; Lewis, W.L.nce; Blau, N.; Harrison, D.G.; Block, P.C.; Quyyumi, A.A., 2003:
Oral tetrahydrobiopterin reduces blood pressure and improves endothelial function in hypertensive patients

Lebovitz, H.E., 2001:
Oral therapies for diabetic hyperglycemia

Michael, J.G.briel; Litwin, A., 2001:
Oral therapy for the treatment of allergies and method of manufacture

Schultz, M.; Cunningham Rundles, S.; Lehn, N.; Falk, W.; Schoelmerich, J., 1999:
Oral therapy with Lactobacillus GG alters the immune response towards Bacteroides sp

Schultz, M.; Cunningham Rundles, S.; Lehn, N.; Falk, W.; Scholmerich, J., 1999:
Oral therapy with lactobacillus GG alters the activation response of PBMC and CD4 T-lymphocytes towards Bacteroides sp

Schultz, M.; Cunningham Rundles, S.; Lehn, N.; Falk, W.; Scholmerich, J., 1999:
Oral therapy with lactobacillus GG alters the proliferative response of PBMC and CD4 T-lymphocytes towards Bacteroides sp

Schulman, S., 2000:
Oral thrombin inhibitors

Kimball, S.D., 1999:
Oral thrombin inhibitors Challenges and progress

Dutta, A.; Chari, P.; Mohan, R.A.; Manhas, Y., 2002:
Oral to nasal endotracheal tube exchange in a difficult airway: a novel method

Maron, R.; Faria, A.M.C.; Weiner, H.L., 1999:
Oral tolarogen generation in nude and B-cell knockout mice after feeding a high dose ovalbumin

Mayer, L., 1999:
Oral tolerance: new approaches, new problems

Guerau D.A.ellano, M.; Maron, R.; Weiner, H.L., 1999:
Oral tolerance and insulin and GAD peptide responses in cyclophosphamide induced diabetes in NOD mice

Spiekermann, G.M.; Walker, W.A., 2001:
Oral tolerance and its role in clinical disease

Strobel, S., 2001:
Oral tolerance and systemic immunoregulation

Caspi, Rachel R., 1999:
Oral tolerance and uveitis

Jones, D.E.J.; Palmer, J.M.; Yeaman, S.J.; Bassendine, M.F.; Kirby, J.A., 1999:
Oral tolerance as a potential therapy in primary biliary cirrhosis

Kato, H.; Fujihashi, K.; Kato, R.; Mcghee, J.R., 2000:
Oral tolerance blocks cholera toxin induced IgA responses

Ilan, Yaron, 2004:
Oral tolerance for treatment of GI inflammation

Song, F.; Campbell, K.A.; Benson, J.M.; Wardrop, R.M.; Gienapp, I.E.; Whitacre, C.C., 2002:
Oral tolerance in experimental autoimmune encephalomyelitis Sites for T cell activation and TCR downregulation in the GALT

Moldoveanu, Z.; Oliver, F.; Mestecky, J.; Elson, C.O., 2005:
Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration

Zhang, X.; Liu, L.; Oida, T.; Weiner, H.L., 2000:
Oral tolerance induces regulatory CD25+CD4+ T cells in ovalbumin TCR transgenic mice

Speciani, A.F.; Fasani, G.; Fumagalli, M.; Barbieri, G.; Gessati, A., 2001:
Oral tolerance induction by low-dose nickel solution Effective and safe treatment of nickel-induced eczema

Yasufuku, K.; Heidler, K.M.; Smith, G.N.; Cummings, O.W.; Wilkes, D.S., 2000:
Oral tolerance induction by type V collagen in lung transplantation

Postlethwaite, A.E.; Wheller, P.; Myers, L.; Kang, A., 2000:
Oral tolerance induction in mice treated with DMARDS

Thurau, S.R.; Diedrichs Mohring, M.; Fricke, H.; Burchardi, C.; Wildner, G., 1999:
Oral tolerance induction in uveitis patients using an HLA-peptide

Pansare, M.; Genyea, C.; Kaplan, J.; Secord, E., 2000:
Oral tolerance induction to anti-factor VIII antibody production in Balb/c mice

Prystupa, K.; Rudzki, E., 2000:
Oral tolerance of nickel in patients with dyshidrosis

Siqueira, A.; Jancar, S.; Foster, P.; Russo, M., 2001:
Oral tolerance prevents the development of airway hyperreactivity and Th2-associated allergic responses in prototypic murine models of asthma

Friedman, A.; Bar Shira, E.; Klipper, E., 2000:
Oral tolerance revisited Innocuous oral antigen induces immune responses in the absence of adjuvant in birds

Secord, E.A.; Pansare, M.; Gao, P.; Kaplan, J., 2001:
Oral tolerance to factor VIII antibody production in neonatal and young mice

Weiner, H.L.; Slavin, A.J.; Maron, R., 1999:
Oral tolerance to glatiramer acetate in MBP T cell receptor transgenic mice

Krause, I.; Blank, M.; Sherer, Y.; Bar Dayan, Y.; Shoenfeld, Y., 2000 :
Oral tolerance to low dose IVIG Immunomodulation of experimental APS

Kjaer, T.M.R.; Frokiaer, H., 1999:
Oral tolerance to ovomucoid is inhibited by simultaneously oral administration of a dietary plant lectin

Jones, D.E.; Palmer, J.M.; Yeaman, S.J.; Kirby, J.A.; Bassendine, M.F., 1999:
Oral tolerance to pyruvate dehydrogenase complex as a potential therapy in primary biliary cirrhosis

Angulo, P.; Van D.W.ter, J.; Gershwin, M.E.; Jorgensen, R.A.; Lindor, K.D., 2002:
Oral tolerance to pyruvate dehydrogenase for treatment of primary biliary cirrhosis A pilot study

Gotsman, I.; Beinart, R.; Safadi, R.; Rabani, E.; Engelhardt, D.; Shouval, D.; Gorecki, M.; Chwdhury, N.R.y; Chowdhury, J.R.y; Ilan, Y., 1999:
Oral tolerance towards hepatitis B antigens in a murine model

Nagler, A.; Gotsman, I.; Pines, M.; Rabbani, E.; Engelhart, D.; Ilan, Y., 1999:
Oral tolerance towards pretransplant antigens alleviates chronic graft versus host disease

Van Puijvelde, G.H.; Van Der Zee, R.; D.V.s, P.; Van Berkel, T.J.; Van Eden, W.; Kuiper, J., 2003:
Oral tolerance with heat shock protein 60 and a heat shock protein 60 peptide reduces atherogenesis

Strobel, S., 2002:
Oral tolerance, systemic immunoregulation, and autoimmunity

Baggi, F.; Andreetta, F.; Milani, M.; Caspani, E.; Simoncini, O.; Longhi, R.; Cornelio, F.; Mantegazza, R.; Antozzi, C., 1999:
Oral tolerization of EAMG in B6 mice by immunodominant epitope Talpha146-162

Brown, J.J.; Parashar, B.; Singh, A.; Rabbani, E.; Engelhardt, D.; Roy Chowdhury, N.; Roy Chowdhury, J., 2000:
Oral tolerization to hepatitis B virus proteins ameliorates hepatic inflammation in Tupaia carrying hepatitis B viral infection

O'malley, R.C.; Mcgrew, W.C., 1999:
Oral tool use among captive orang utans

Petroff, O.A.; Hyder, F.; Mattson, R.H.; Rothman, D.L., 1999:
Oral topiramate rapidly increases brain GABA in patients with epilepsy

Loos, W.J.; Sparreboom, A.; Verweij, J.; D.J.nge, M.J.A., 2000:
Oral topotecan in adults should not be dosed by body-surface area

Ozaki, M.; Takahara, T.; Kakiuchi, M.; Nakamura, K.; Yamaoka, R., 2001:
Oral toxicity of monoterpenes and appetite-reducing effects of their odors in the blowfly, Phormia regina

Welch, S.L., 2002:
Oral toxicity of topical preparations

Thanavala, Y.; Lugade, A.A., 2010:
Oral transgenic plant-based vaccine for hepatitis B

Baron, S.; Ganceres, N.; Nguyen, D.; Poast, J., 2001:
Oral transmission of HIV Biophysical vs molecular defenses in saliva

Acharya, R.N.; Baker, J.L., 2001:
Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity

Zhang, H.; Croft, J., 2001:
Oral transmucosal drug dosage using solid solution

Danjoux, C.; Chow, E.; Wong, R.; Connolly, R.; Andersson, L.; Franssen, E.; Stefaniuk, K.; Schueller, T.; Pope, J.; Szumacher, E.; Hayter, C., 2000 :
Oral transmucosal fentanyl citrate for incidental pain in radiotherapy patients An innovative approach

Noguera, M.A.; D'ocon, P.; Gisbert, R.; Miquel, R.; Anselmi, E.; Ivorra, M.D., 2003:
Oral treatment of spontaneously hypertensive rats with prazosin, nifedipine or captopril changes noradrenaline-sensitive internal Ca2+ stores in vessels

Lee, Y.W.; Overstreet, D.H.; Yang, Y.; Luan, Y.; Fang, Q.C., 1999:
Oral treatment with NPI-031G reduces alcohol intake in high alcohol drinking rats

Van Ginckel, R.; Floren, W.; Moelans, P.; Janssens, B.; Molenberghs, K.; Wouters, W., 1999:
Oral treatment with R101933 restores the sensitivity towards paclitaxel and adriamycin in resistant human tumors xenografted in athymic mice

Henriksen, E.J.; Johnson, K.W.; Kinnick, T.R.; O'keefe, M.P.; Harrison, S.D., 2001:
Oral treatment with a glycogen synthase kinase-3 inhibitor improves glucose tolerance and skeletal muscle glucose transport activity in Zucker Diabetic Fatty rats

Collins, S.M.; Galeazzi, F., 1999:
Oral treatment with ethanol aggravates experimental colitis in mice

Overstreet, D.H.; Yang, Y.; Du, Q.Z.; Lee, Y.W., 1999:
Oral treatment with kudzu extract reduces alcohol intake in high alcohol drinking rats

Hougee, S.; Vriesema, A.J.M.; Wijering, S.C.; Knippels, L.M.J.; Folkerts, G.; Nijkamp, F.P.; Knol, J.; Garssen, J., 2010:
Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study

Cunliffe, W.J.; Aldana, O.L.; Goulden, V., 1999:
Oral trimethoprim: a relatively safe and successful third-line treatment for acne vulgaris

Mathew, N.T.; Kailasam, J.; Fischer, A.S., 2001:
Oral triptans are effective and well-tolerated in migraine with neurological symptoms

Daniel, R.; Trovafloxacin Study Group, 1999:
Oral trovafloxacin compared with amoxicillin for the treatment of mild to moderate community-acquired pneumonia

Luke, D.R., 1999:
Oral trovafloxacin versus intravenous cefoxitin in elective hysterectomy

Peterson, J.; Trovafloxacin Study Group, 1999:
Oral trovafloxacin vs oral cefuroxime +- erythromycin in community-acquired pneumonia

Fabro, R.S.; Pelayo, A., 1999:
Oral tube holder

Molina, M.; Herrero, J.A.; Ortega, N.; Gomez, J., 2001:
Oral tuberculosis Epidemiologic factors, clinical course and outcome

Bernard, B.K.; Hoberman, A.M.; Brown, W.R.y; Ranpuria, A.K.; Christian, M.S., 2002:
Oral two-generation reproduction study of pentachlorophenol in rats

Christian, M.S.; York, R.G.; Hoberman, A.M.; Fisher, L.C.; Brown, W.R.y, 2002:
Oral two-generation reproductive toxicity study of bromodichloromethane in rats

Christian, M.S.; York, R.G.; Hoberman, A.M.; Frazee, J.; Fisher, L.C.; Brown, W.R.; Creasy, D.M., 2002:
Oral two-generation reproductive toxicity study of dibromoacetic acid in rats

Myers, L.K.; Higgins, G.; Thomson, J.; Walton, C.; Hendricks, J.; Kerr, N.; Pandya, P.; Shlopov, B.; Seyer, J.M.; Postlethwaite, A.E.; Kang, A.H., 1999:
Oral type II collagen in JRA

Orchard, T.R.; Vaughan, R.; Welsh, K.I.; Jewell, D.P., 1999:
Oral ulceration and polymorphisms of the MHC class I chain like gene A in peripheral arthropathies of inflammatory bowel disease

Garrigue, V.; Canet, S.; Dereure, O.; Panabieres, O.; Augias, D.; Chong, G.; Mourad, G., 2001:
Oral ulcerations in a renal transplant recipient: a mycophenolate mofetil-induced complication?

Syrjanen, S.; Leimola Virtanen, R.; Schmidt Westhausen, A.; Reichart, P.A., 1999:
Oral ulcers in AIDS patients frequently associated with cytomegalovirus and Epstein-Barr virus infections

Huang, G.S.; Yang, S.M.; Wang, C.B., 2000:
Oral uptake of chitosan inhibits growth of B16 melanoma in mouse

Goker, E.; Aykan, N.F.; Serdengecti, S.; Gunel, N.; Alakavuklar, M.; Icli, F.; Yucel, I.; Uskent, N.; Arpaci, F.; Firat, D., 1999:
Oral uracil/tegafur plus leucovorin in patients with metastatic colorectal cancer

Saydoff, J.A.; Liu, L.S.; Hu, Z.Y.; Noble, M.M.; Tandon, P.; Garcia, R.A.G.; Von Borstel, R.W., 2001:
Oral uridine prodrug PN401 protects mice against azide toxicity in vivo Studies on the mechanism of uridine neuroprotection in vitro

Hu, Z.Y.; Liu, L.S.; Tandon, P.; Brenneman, D.; Cardin, S.; Von Borstel, R.W.; Saydoff, J.A., 2002:
Oral uridine prodrug pn401 is neuroprotective in neuroinflammatory models of alzheimers disease

Venhoff, N.; Lebrecht, D.; Deveaud, C.; Beauvoit, B.; Bonnet, J.; Müller, K.; Kirschner, J.; Venhoff, A.C.; Walker, U.A., 2011:
Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analogues

Colburn, K.K.; Langga Sharifi, E.M.; Lee, M.L., 1999:
Oral use of intravenous immunoglobulin for the treatment of rheumatoid arthritis

Aldwell, F.E.; Buddle, B.M.; Tucker, I.M., 2002:
Oral vaccination against tuberculosis

Russell Jones,; Howe, P.; D.A.zpurua, H.J.mes; Rand, K.N.rman, 2000:
Oral vaccines

Hunter, R.L.; Bennett, C.E., 1999:
Oral vaccines comprising multiple emulsions and methods of preparation

Spruance, S.L.; Jones, T.M.; Blatter, M.M.; Vargas Cortes, M.; Barber, J.; Goldstein, D.; Schultz, M., 2002:
Oral valaciclovir for the treatment of herpes labialis Two trials of early, high-dose, short-course therapy

Aslanides, I.M.; D.S.uza, S.; Wong, D.T.W.; Giavedoni, L.R.; Altomare, F.; Detorakis, E.T.; Kymionis, G.D.; Pallikaris, I.G., 2002:
Oral valacyclovir in the treatment of acute retinal necrosis syndrome

Liesveld, J.L.; Abboud, C.N.; Lancet, J.; Ifthikharuddin, J.J.; Oliva, J.L.; Wedow, L.A.; Stamm, C.; Nichols, D., 2001:
Oral valacyclovir vs intravenous acyclovir in prevention of herpes simplex virus infections in autologous stem cell transplantation patients

von Kries, R., 1999:
Oral versus intramuscular phytomenadione: safety and efficacy compared

Dennison, J.D.vid; Quernin, M.H.; A.K.ndi, S.; Muralitharan, S.; Tauro, M.; Kanan, K.; Daar, S.; A.Z.djali, S.; Pathare, A.; Zia, F.; Nusrat, N.; U.R.hman, J.; Taqi, A.; Jacqz Aigrain, E.; Ganguly, S.S.ndar; Krishnamoorthy, R., 2003:
Oral versus intravenous busulfan in bone marrow transplantation for thalassemia

Mazess, R.B.; Elangovan, L., 2002:
Oral versus intravenous vitamin D hormone therapy in dialysis patients

Pinto, E.F.; Cortezia, M.M.; Lima, G.F.; Rodrigues Junior, J.M.; Rossi Bergmann, B., 2000:
Oral versus subcutaneous immunization with leishmanial Ag encapsulated in microspheres A new strategy for protection in murine leishmaniasis

Heyneman, C.A.; Lawless-Liday, C.; Wall, G.C., 2000:
Oral versus topical NSAIDs in rheumatic diseases: a comparison

Fisher, S.; Davies, G.; Mackenzie, P., 2001:
Oral versus vaginal misoprostol for induction of labour A double-blind, placebo-controlled randomised trial

Danielson, D.W.; Nichols, E.; Husband, B., 2000:
Oral veterinary composition containing a fluoroquinolone antibacterial agent possessing superior absorption properties and an extended duration of therapeutic antimicrobial blood levels, and a method of treating microbial infection in a ruminant

Miller, J.W.; Green, R.; Herbert, V.D.; Flynn, M.A., 1999:
Oral vitamin B12 supplementation decreases homocysteine in healthy elderly people with suboptimal vitamin B12 status

Campbell, A.K.L.mon; Miller, J.W.; Green, R.; Haan, M.N.; Allen, L.H., 2003:
Oral vitamin B12 supplements normalize plasma B12 and homocysteine, but have an insignificant effect on functional outcomes, in Latino elderly with marginal B12 status

Raitakari, O.T.; Adams, M.R.; Mccredie, R.J.; Griffiths, K.A.; Stocker, R.; Celermajer, D.S., 1999:
Oral vitamin C and endothelial function in smokers Acute improvement, but no sustained beneficial effect

Mak, J.C.S.; Stuart-Harris, J.; Cameron, I.D.; Mason, R.S., 2010:
Oral vitamin D replacement after hip fracture: a comparative review

Kuan, J.K.; Brock, G.B., 2003:
Oral vitamin E and folic acid supplementation during sildenafil therapy for erectile dysfunction improves salvage in non-responders

Cho, B.; Kim, H.K.; Kim, C.C.oo; Lee, J.W.ok, 1999:
Oral vitamin E and glutathione for the prevention and early treatment of veno-occlusive disease in children with acute leukemia undergoing hematopoietic stem cell transplantation

Wright, S.; Westland, G.; Jeffrey, R.R.; Watson, H.G., 2004:
Oral vitamin K does not affect vitamin K-dependent coagulation factors in normal individuals

Bond, S.; Rhodes, S.; Taylor, M.; Sansum, K.; Green, E.S., 2002:
Oral vitamin K for excessively anticoagulated patients who are not bleeding is safe and effective

Levitsky, J.; Ehrenpreis, E.D.; Jani, A.B.; Ahn, J.; Hong, J.J., 2003:
Oral vitamin a for the treatment of chronic radiation proctopathy a randomized, controlled trial

Schleuning, M.; Judith, D.; Thoedtmann, R.; Baurmann, H.; Schwerdtfeger, R., 2003:
Oral voriconazole for prophylaxis of fungal infections during allogeneic hematopoietic stem cell transplantation in patients at risk

Jehn, U.; Suciu, S.; Thomas, X.; Varet, B.; Muus, P.; Berneman, Z.; Marie, J.P.; Broccia, G.; Fillet, G.; Mandelli, F.; Nobile, F.; Ricciuti, F.; Leone, G.;, 2002:
Oral vs Intravenous Consolidation Chemotherapy in Elderly Patients with AML Results of the EORTC-GIMEMA AML-13 Phase III Trial

Bradley, J.S., 1999:
Oral vs. intramuscular antibiotic therapy for acute otitis media: which is best?

Paul, M.; Vidal, L.; Ben Dor, I.; Soares Weiser, K.; Leibovici, L., 2003:
Oral vs intravenous antibiotic treatment for febrile neutropenia A meta-analysis

Atherly John, Y.C.; Cunningham, S.J.; Senturia, Y.D.; Crain, E.F., 2001:
Oral vs intravenous rehydration in the pediatric emergency department

Tojimbara, T.; Kimikawa, M.; Nakajima, I.; Sato, S.; Nakamura, M.; Ishida, H.; Tanabe, K.; Koyama, I.; Utsumi, K.; Sannomiya, A.; Tsuji, K.; Fuchinoue, S.; Agishi, T., 1999:
Oral vs intravenous tacrolimus-based induction therapy in renal transplantation

Larsen, H.H.; Huang, L.; Kovacs, J.A.; Crothers, K.; Silcott, V.A.; Morris, A.; Turner, J.R.; Beard, C.B.; Masur, H.; Fischer, S.H., 2003:
Oral washes for diagnosis of Pneumocystis pneumonia in patients with HIV infection using quantitative touch-down PCR

Zapatero, L.; Martínez, M.I.; Alonso, E.; Salcedo, G.; Sánchez-Monge, R.; Barber, D.; Lombardero, M., 2003:
Oral wheat flour anaphylaxis related to wheat alpha-amylase inhibitor subunits CM3 and CM16

A.Hady, Essam M., 2000:
Oral zinc sulphate treatment and supplementation to cases of acrodermatitis enteropathica and severe protein enegy malnutrition specially kwashiorkor

Iwasaki, S.; Suzuki, R.; Nomura, K.; Hasegawa, T.; Ito, Y.; Yoshimura, A.; Ideura, T., 2001:
Oral zinc supplementation reduces mean erythropoietin dose in EPO-required hemodialysis patients

Beckman, N.; Houston, S.; Hentges, D.; Boudreau, N.; Ferguson, M.; Bender, S.; Voss, A., 2002:
Oral zinc supplementation, pressure ulcer development and healing in long-term care residents

Singer, R.; Tuchman, M.; Abu Shakra, S., 2003:
Oral zolmitriptan demonstrates high efficacy in the acute treatment of true menstrual migraine

Loder, E.; Silberstein, S.; Giammarco, R.; Smith, T.; Mueller, L.; Abu Shakra, S., 2002:
Oral zolmitriptan exhibits efficacy as early as 30 minutes in menstrually associated migraine Results of a large multicenter placebo-controlled study

Goadsby, P.J.; Gawel, M.; Hardebo, J.E.ik; Millson, D.; Bahra, A.; Breen, S., 1999:
Oral zolmitriptan is effective in the acute treatment of episodic cluster headache

Tuchman, M.; Abu Shakra, S.; Silberstein, S.D.; Dodick, D., 2003:
Oral zolmitriptan is efficacious as acute therapy for pure menstrual migraine Results of a second large prospective, multicenter, placebo-controlled Trial

Ferrero, G.B.; Valenzise, M.; Sorasio, L.; Franco, B.; Defilippi, C.; Pepe, E.; Silengo, M., 2001:
Oral, facial, digital, vertebral anomalies with psychomotor delay An OFD variant or a new syndrome?

Petersen, P., 2003:
Oral, fixed-dose ximelagatran, without dose titration or coagulation monitoring, is well tolerated and at least as effective as well-controlled warfarin

Dietrich, R.; Ney, H., 1999:
Oral-administration forms of a medicament containing pantoprazol

Toriello, Helga V., 2003:
Oral-facial-digital syndrome I

Rudenskaya, G.E.; Prityko, A.G.; Gonchakov, G.V.; Yasonov, S.A., 2000:
Oral-facial-digital syndrome type I

Ward, David M., 2001:
Oral-facial-digital syndrome type I unrecognised until age 46 in a woman diagnosed as adult-type polycystic kidney disease

Athanikar, Narayan, 2002:
Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases

Levitsky, G.; Colman, J.L.; Brown, S., 2002:
Oral/nasal cannula

Guevava, M.; Modi, P.; Guevara Aguirre, J.; Saavedra, J.; Baldeon, G.; Moncayo, P.; Llore, L.; Benitez, E., 2002:
Oralin as a meal insulin in treatment of Type 2 diabetes

Juturu, V.; Komorowski, J.R.; Gudi, R., 2004:
Orally Administered Arginine Silicate Inositol Complex Is Not Clastogenic In Chinese Hamster Ovary Cells

Hama, Susan H., 2004:
Orally Administered Statins and an ApoA-I Mimetic Peptide Act Synergistically to Render ApoE Null Mouse HDL Anti-inflammatory

Chen, C.; Wilcoxen, K.; Bozigian, H.; Chen, T.; Cha, M.; Mccarthy, J.R.; Huang, C.Q.; Haddach, M.; Zhu, Y.F.i; Murphy, B.; D.S.uza, E.B.; Grigoriadis, D.E., 2001:
Orally active 3- pyrazolo pyrimidines as nonpeptide CRF1 receptor antagonists

Blackburn, B.K.; Melville, C.; Zablocki, J.A.; Palle, V.P.; Elzein, E.O.; Wang, L., 2003:
Orally active A1 adenosine receptor agonists

Kitamura, S.; Fukushi, H.; Miyawaki, T.; Kawamura, M.; Terashita, Z.I.hi; Naka, T., 2001:
Orally active GPIIb/IIIa antagonists Synthesis and biological activities of masked amidines as prodrugs of 2- -4- -2- -3- propanoyl-3-

Loozen, H.J.n Jozef; Leysen, D.; Louw, J.V.n Der, 2004:
Orally active androgens

Chaudhary, S.; Puri, S.K.; Singh, C., 2003:
Orally active artemisinin derivatives

Posner, G.H.; Paik, I.H.; Mcriner, A.J.; Sur, S.; Borstnik, K.; Xie, S.; Shapiro, T.A., 2003:
Orally active artemisinin-derived trioxane dimers

Chin, A.P.; Bernhardt, P.V.; Richardson, D.R., 2003:
Orally active chelators for the treatment of iron overload diseases

Huggins, J.W.; Baker, R.O.; Beadle, J.R.; Hostetler, K.Y., 2002:
Orally active ether lipid prodrugs of cidofovir for the treatment of smallpox

Nag, B.; Medicherla, S.; Sharma, S.D., 2000:
Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes

Allaudeen, H.; Ramaswamy, M.; Radhakrishnan, B.; Rajagopalan, J.; Rajotte, R.V., 1999:
Orally active insulin A single insulin conjugate selected for future studies

Meyerhoff, C.; Stern, W.; Beer, B.; Ramaswamy, M.; Allaudeen, H., 1999:
Orally active insulin Proof of concept study in normal volunteers

Merson, L.; Olivier, N., 2002:
Orally active iron chelators

Dumas, J.; Hatoum Mokdad, H.; Sibley, R.N.; Smith, R.A.; Scott, W.J.; Lee, W.; Wood, J.; Wolanin, D.; Cooley, J.; Bankston, D.; Redman, A.; Schoenleber, R.; Caringal, Y.; Housley, T.J.; Wil, 2001:
Orally active p38 kinase inhibitors from the urea class

Nag, B.; Medicherla, S.; Dey, D., 1999:
Orally active peptides for the treatment of Type I and Late-Stage Type II diabetes

Wang, W.; Borchardt, R.T.; Wang, B., 2000:
Orally active peptidomimetic RGD analogs that are glycoprotein IIb/IIIa antagonists

Shimizu, Y.; Nagaya, N.; Satoh, T.; Uematsu, M.; Kyotani, S.; Sakamaki, F.; Nakanishi, N.; Miyatake, K., 2000:
Orally active prostacyclin analogue improves exercise capacity in patients with primary or thromboembolic pulmonary hypertension

Fraley, M.E.; Karki, S.B.; Kim, Y., 2003:
Orally active salts with tyrosine kinase activity

Pandey, B.; Balse, P.; Nag, A.; Gutala, S.; Neogi, P.; Nag, B.; Dey, D., 2004:
Orally active small molecule inhibitors of TNF- alpha and COX-2 for the treatment of Inflammatory disorders

Wright, J.; Boxer, P.; Gregory, T.; Huang, J.C.eng; Hong Bae, S.; Kaller, M.; Kesten, S.; Meltzer, L.; Upasani, R.; Whittemore, E.; Wise, L.; Woodward, R.; Yang, K.; Zhou, Z.L.n, 2000:
Orally active subtype-selective NMDA receptor antagonists for the treatment of Parkinsons disease

Chang, L.L.; Truong, Q.; Doss, G.; Lin, L.; Magriotis, P.A.; Maccoss, M.; Lyons, K.; Mccauley, E.; Mumford, R.A.; Van Riper, G.; Vincent, S.; Schmidt, J.A.; Hagmann, W.K., 2002:
Orally active, conformationally constrained small molecule VLA-4 antagonists

Dey, D.; Nag, A.; Pandey, B.; Gupta, A.; Sriram, S.; Agarwal, S.K.mar; Nag, B., 2003:
Orally active, small molecule TNFalpha inhibitor for the treatment of inflammatory disorders

Saslawski, O.; Giet, P.; Michel, D.; Holot, T., 2003:
Orally administerable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent

Maeda, N.Y.; Bydlowski, S.P.; Lopes, A.A., 1999:
Orally administered acetylsalicylic acid decreases protein incorporation into the cytoskeleton of thrombin-stimulated platelets

Mottet, N.; Bressolle, F.; Costa, P.; Chaufour, S.; Rauch, C.; M.C.rthy, C.; Magnier, G., 2000:
Orally administered alfuzosin has a high prostatic diffusion in benign prostatic hyperplasia tissue

Shulman, Morton, 2001:
Orally administered analgesic composition comprising myfadol

Hu, O.Y.a Pu; Hsiong, C.H.ei, 2004:
Orally administered analgesic compositions containing nalbuphine

Allendorf, D.J.; Baran, J.T.; Hansen, R.D.; Subbarao, K.; Walsh, D.; Hong, F.; Marroquin, J.; Yan, J.; Lambris, J.D.; Haribabu, B.; Ross, G.D., 2003:
Orally administered beta-glucan functions via anti-tumor mAbs and the complement system to recruit CR3+ neutrophils and macrophages that produce tumor regression and tumor-free survival

Macy, J.D.; Troiano, N.; Gundberg, C.; Gilligan, J.; Vignery, A., 1999:
Orally administered calcitonin prevents bone loss induced by ovariectomy in rats

Talwar, N.; Sen, H.; Staniforth, J.N., 2001:
Orally administered controlled drug delivery system providing temporal and spatial control

Lavi, I.; Levinson, D.; Peri, I.; Nimri, L.; Hadar, Y.; Schwartz, B., 2010:
Orally administered glucans from the edible mushroom Pleurotus pulmonarius reduce acute inflammation in dextran sulfate sodium-induced experimental colitis

Zhang, Y.; Rodell, T.; Murphy, T.M.; Robinson, C.E.; Banan, A.; Choudhary, S.; Keshavarzian, A., 2000:
Orally administered glutathione peroxidase-mimetic is a potent anti-oxidant Protection against oxidation and nitration of inflamed colonic mucosa in patients with ulcerative colitis

Opal, S.M.; Keith, J.C.; Palardy, J.E.; Parejo, N.A., 2000:
Orally administered human recombinant interleukin-11 microparticulates maintain intestinal mucosal integrity and decrease microbial invasion in experimental neutropenic sepsis

Musabayane, C.T.; Bwititi, P.; Munjeri, O.; Osim, E.E., 1999:
Orally administered pectin insulin hydrogel beads sustain insulin release in streptozotocin-diabetic rats

Fogelman, A.M.; Anantharamaiah, G.M.; Navab, M., 2003:
Orally administered peptides to ameliorate atherosclerosis

Lee, F.Y.; Chen, S.C.iung; Kuo, H.C.iang, 2001:
Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same

Kawamura, Yukio, 1999:
Orally administered protein and innate immunity

Mali, S.; Gupte, R.; Deshpande, J.; Ranbhan, K., 2003:
Orally administrable acid stable antiulcer benzimidazole derivatives

Farah, N.; Denis, J., 2000:
Orally administrable composition capable of providing enhanced bioavailability when ingested

Tester, R.F.ank; Karkalas, J., 2003:
Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract

Gross, J.; Kelly, J.G.rard, 1999:
Orally administrable delivery device

Saslawski, O.; Giet, P.; Michel, D.; Holot, T., 2002:
Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent

Lee, F.Y.; Chen, S.C.iung; Kuo, H.C.iang, 2001:
Orally administrable nifedipine pellet and process for the preparation thereof

Oshlack, B.; Chasin, M., 1999:
Orally administrable opioid formulations having extended duration of effect

Liebowitz, S.M.; Stupak, E.I.; Chaudry, I.A.; Vadino, W.A.; Bowen, F.E., 2002:
Orally administrable solid dosage form

Liebowitz, S.M.; Stupak, E.I.; Chaudry, I.A.; Vadino, W.A.; Bowen, F.E., 2002:
Orally administrable solid ribavirin dosage forms and process for making them

Adeyeye, C.M.ji; Ichikawa, H.; Fukumori, Y., 2000:
Orally administrable time release drug containing products

Arimilli, M.N.; Dougherty, J.P.; Cundy, K.C.; Bischofberger, N., 1999:
Orally bioavailable acyclic nucleoside phosphonate prodrugs Adefovir Dipivoxil and Bis PMPA

Liu, M.; Bishop, W.R.; Nielsen, L.L.; Bryant, M.S.; Kirschmeier, P., 2001:
Orally bioavailable farnesyltransferase inhibitors as anticancer agents in transgenic and xenograft models

Pasternak, A.; Marino, D.; Vicario, P.P.; Ayala, J.M.; Cascieri, M.A.; Parsons, W.H.; Mills, S.G.; Maccoss, M.; Yang, L., 2003:
Orally bioavailable gamma-aminoamide CCR2 antagonists

Marquis, R.W.; Ru, Y.; Erhardt, K.F.; Gribble, A.D.; Witherington, J.; Fenwick, A.; Garnier, B.; Bradbeer, J.; Lark, M.; Gowen, M.; Tomaszek, T.A.; Tew, D.G.; Zhao, B.; Smith, W.W.; Janson, C.A.; D'alessio, K.J.; Mcqueney, M.S.; Abdel Meguid, S., 1999:
Orally bioavailable inhibitors of the cysteine protease cathepsin K

Siebert, J.M.; Khankari, R.K.; Kositprapa, U.; Pather, S.I.diran, 2002:
Orally disintegrable tablet forming a viscous slurry

Shimizu, T.; Morimoto, S.; Tabata, T., 2001:
Orally disintegrable tablets

Devries, T.; Valentine, W.; Valentine, W.K., 2002:
Orally dissolvable nutritional supplement

Kiszka, I.; Wierzbicki, A.; Kaneko, H.; Wasik, T.J.; Kaneko, Y.; Kozbor, D., 2000:
Orally induced mucosal and systemic immunity to the HIV envelope glycoprotein by prime-boost immunization strategies

Peet, N.P.; Angelastro, M.R.; Burkhart, J.P., 2001:
Orally-active elastase inhibitors

Hoekstra, William J., 2001:
Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders

Soos, J.M.; Schiffenbauer, J.; Johnson, H.M.rcellus, 2002:
Orally-administered interferon-TAU compositions and methods

Ohashi, K.; Kurimoto, M., 2001:
Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases

Quaglino, A.; Erichsen, A.L.; Craig Veit, C.B.; Viant, M.R.; Fry, D.M.; Millam, J.R., 1999:
Orally-dosed xenobiotic estrogens masculinize brain and behavior in the female zebra finch

Romero, F.A.; Silkoff, P.E.; Milgrom, H.; Townley, R.G., 2000:
Orally-exhaled nitric oxide correlates with serum IgE levels in children with atopic asthma

Lee, R.; Huber, K.; Roth, R.; Brunner, L.; E.H.san, A.; Cheung, J.; Bohner, B., 2002:
Orange County quick and easy asthma population management strategy

Goodner, K.L.; Manthey, J.A., 2001 :
Orange juice The naturally nutritious drink

Vanapalli, S.R.; Chen, Y.; Ellingrod, V.L.; Kitzman, D.; Lee, Y.; Hohl, R.J.; Fleckenstein, L., 2003:
Orange juice decreases the oral bioavailability of ivermectin in healthy volunteers

Lilja, J.J.; Juntti Patinen, L.; Neuvonen, P.J., 2003:
Orange juice greatly reduces plasma concentrations of celiprolol

Kurowska, E.M.; Spence, J.D.vid; Jordan, J.; Wetmore, S.; Freeman, D.J.; Piche, L.A.; Serratore, P., 1999:
Orange juice increases plasma HDL cholesterol and reduces the LDL/HDL cholesterol ratio in moderately hypercholesterolemic subjects

Cannon, B.; Jabeen, T.; Whelton, M.J., 2000:
Orange livers in Southern Ireland

Fan, K.; Kurihara, N.; Abe, S.; Yang, K.; Lipkin, M., 2003:
Orange peel extract inhibits intestinal tumor growth in ApcMin mice

Fambrini, M.; Michelotti, V.; Pugliesi, C., 2010:
Orange, yellow and white-cream: inheritance of carotenoid-based colour in sunflower pollen

Inacio, J.; Fonseca, A.; Spencer Martins, I., 2003:
Orange-pigmented yeasts from the phylloplane Taxonomic characterisation and direct molecular detection on leaves

Sutherland, Jamie P., 2001:
Orange-tip Anthocharis cardamines recorded from Brassica rapa

Van Schaik, C.P., 2003:
Orangutan cultures and the comparative study of culture

Macdonald, S.E.; Agnes, M.M., 1999:
Orangutan spatial memory and behavior in a foraging task

Van Schaik, C., 2001:
Orangutan traditions and their implications

Netter, M.; Schibli, R.; Scapozza, L.; Schubiger, A., 2003:
Oranometallic Re- and 99mTc-tricarbonyl-complexes of thymidine analogues Synthesis, structure-activity relationships, and biological evaluation

Ardies, C.M.rray; Karmali, R., 2001:
Orazamide orotate may attenuate doxorubicin induced lipid peroxidation and TNF content in heart

Viru, A.; Tipton, C.M., 2000:
Orbeli A Russian scientist to be remembered by exercise and cardiovascular physiologists

Mooney, M.; Weinberg, S.; Neiswanger, K.; Faix, R.; Richardson, D.; Petiprin, S.; Bardi, K.; Giles, R.; Carter, E.; Bowen, A.; Mazarita, M.L., 2002:
Orbicularis oris muscle morphology in individuals with cleft lip with or without cleft palate and their relatives

Bernardino, C.R.; Chang, E.L.; Fay, A.M.; Rubin, P.A.D., 2002:
Orbital Fractures Associated with Ocular Trauma - Clincal Features

Unal, M.; Konuk, O.; Atasever, T.; Ayvaz, G.; Yetkin, I.; Cakir, N.; Arslan, M.; Karakoc, A.; Egehan, I., 2000:
Orbital Gallium-67 scintigraphy A useful method to evaluate disease activity in Graves orbitopathy

Ahmed, S.; Fuchs, A.; Mehrotra, B., 2002:
Orbital Lymphomas A Single Institution Experience

Islam, N.; Mireskandari, K.; Rose, G., 2002 :
Orbital Varix And Wall Defects - Case Series

Engelman, C.J.; Palmer, J.D.; Egbert, P., 2004:
Orbital abscess following subtenon triamcinolone injection

Nishimura, T.; Koga, T.; Kobayashi, K.; Kobayashi, H.; Okinami, S.; Toda, S.; Sugihara, H., 2001:
Orbital adipocytes promote proliferation of corneal epithelial cells in reconstruction culture

Shepler, T.R.; Char, D.H., 2002:
Orbital and Eyelid Capillary Hemangiomas A Retrospective Look at 24 Consecutive Cases

Ray, S.K.; Hatton, M.P., 2001:
Orbital and adnexal trauma in open globe injuries

Guillou, L.; Coindre, J.M., 2000:
Orbital and extraorbital giant cell angiofibroma A giant cell-rich variant of solitary fibrous tumor

Colson, A.E.; Daily, J.P., 1999:
Orbital apex syndrome and cavernous sinus thrombosis due to infection with Staphylococcus aureus and Pseudomonas aeruginosa

Kurz, P.A.; Yung, R.; Harris, A., 2000:
Orbital blood flow pattern in patients with posterior ischemic optic neuropathy after surgery under general anesthesia

Fetkenhour, D.R.; Shields, C.L.; Chao, A.N.; Shields, J.A.; Guterman, C.B.; Eagle, R.C., 2001:
Orbital cavitary rhabdomyosarcoma masquerading as lymphangioma

Rachid, M.D.; Balli, F.; Carvalho, M.G.; Lucena, E.G.; Pinto, M.A., 2000:
Orbital cellulitis Review of 24 cases from a public health institution in Brazil

Kikkawa, D.O.; Heinz, G.W.; Martin, R.T.; Nunery, W.N.; Eiseman, A.S., 2002:
Orbital cellulitis and abscess secondary to dacryocystitis

Laviña, A.M.; Creasy, J.L.; Tsai, J.C., 2002:
Orbital cellulitis as a late complication of glaucoma shunt implantation

Morgan, S.J., 2003:
Orbital cellulitis following corneal gluing under sub-Tenon's local anaesthesia

Jacquemin, C.; Bosley, T.; Mullaney, P., 2000:
Orbital color Doppler imaging of optic nerve tumors

Trumpower, P.J., 1999:
Orbital convergence in small-bodies arboreal, nocturnal mammals Implications for primate origins

Rath, S.; Honavar, S.G.; Naik, M.; Anand, R.; Agarwal, B.; Krishnaiah, S.; Sekhar, G.Chandra., 2010:
Orbital cysticercosis: clinical manifestations, diagnosis, management, and outcome

Morse, S.A.; Callas, P.L.; Orth, G.A.; Frazier, A.G.C.; Chin, A.K., 1999:
Orbital dissection cannula and method

Sires, B.S.; Garwin, G.G.; Saari, J.C.; Hurst, J.S.; Van Kuijk, F.J., 2000:
Orbital fat Why the color difference?

Shiratori, C.A.; Schellini, S.A.; Marques, M.E.A.; Padovani, C.R., 2003:
Orbital fat histologic changes after experimental evisceration and enucleation

Hintschich, C.; Zonneveld, F.W.; Koornneef, L.Y., 2002:
Orbital fat in the acquired anophthalmic socket

Cochrane, S.R.; Hall, A.J.H.; Stawell, R.J., 2000:
Orbital floor steroids in non-necrotising scleritis

Hatton, M.P.; Watkins, L.M.; Rubin, P.A.D., 2000:
Orbital fractures in children A retrospective analysis

Putnam, K.M.; Pizzagalli, D.A.; Gooding, D.C.; Kalin, N.H.; Davidson, R.J., 2003:
Orbital frontal cortex activation and diurnal variation in cortisol evidence from brain electrical tomography analysis of high - density EEG data

Gözdaşoğlu, S.; Yavuz, G.; Unal, E.; Taçyldz, N.; Cavdar, A.O., 2002:
Orbital granulocytic sarcoma and AML with poor prognosis in Turkish children

Dareau, S.; Gros, T.; Bassoul, B.; Causse, L.; Eledjam, J.J., 2003:
Orbital haemorrhage after medial canthus episclera anaesthesia

Goldsmith, J.D.; Van D.R.jn, M.; Syed, N.A., 1999:
Orbital hemangiopericytoma and solitary fibrous tumor Lesions of similar pathogenesis?

Syed, N.A.; Goldsmith, J.D.; Van D.R.jn, M., 1999:
Orbital hemangiopericytoma and solitary fibrous tumor Neoplasms of similar pathogenesis?

Kaymaz, M.; Dogulu, F.; Kurt, Gökhan.; Kardes, Oür.; Baykaner, M.Kemali., 2002:
Orbital hydatid cyst. Case illustration

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file: